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Chapter 1  General Introduction 
 
1–1. Substrate Oxidation by Natural Enzymes 
In biological systems, enzymes perform various reactions to keep the lives. Among the reactions, 
oxidations are especially important, as observed in metabolism, photosynthesis, and so on. In the oxidation 
processes, transition-metal elements such as iron and copper, which are coordinated by amino-acid residues, 
porphyrin, or heteroaromatic enzymes as ligands, play principal roles.1-3 Oxidation enzymes including 
cytochrome P450, flavin-containing monooxygenases and pterin-dependent enzymes form active species to 
oxidize substrates with use of one dioxygen molecule as a sacrificial oxidant.1a As described below, 
dioxygen activation in the oxidation enzymes is well sophisticated to let the active center of the enzymes 
efficiently react with a dioxygen molecule, which is known to be inert due to its triplet ground state.4 In 
nature, both of the dioxygen activation and substrate oxidation with the active species in the oxidation 
enzymes utilize "Proton-Coupled Electron Transfer (PCET)" to lower the energy barrier of the reactions (See 
Chapter 1-4). 
Cytochrome P450s are one of representative examples of oxidation enzymes conducting dioxygen 
activation to obtain the active species, and they contain an iron(III)-porphyrin complex at their active center. 
In the dioxygen activation process, the iron(III)-porphyrin accepts one electron and the reduced porphyrin 
Figure 1. Coenzymes of oxidation enzymes in their active forms. (A) Compound I, (B) flavin-hydroperoxide, (C) PQQ, (D) 
CTQ, (E) TTQ, (F) TPQ, (G) LTO. 
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reacts with a dioxygen molecule to generate the active species, so-called "Compound I" (Figure 1-1), which 
is an iron(IV)-oxo-(porphyrin-π-radical-cation) species.1 Compound I shows high electron-acceptability with 
use of the high-valent metal center and also exhibits high proton-acceptability with use of the –2-charged 
oxo ligand, and the acceptabilities bring the high oxidation power to compound I to oxidize even C-H bonds. 
Flavins are heteroaromatic coenzymes to perform various redox reactions that are important in 
metabolism.3a In flavin-dependent enzymes, 2e–-reduced flavin reacts with dioxygen to form flavin 
C4a-hydroperoxide species as the active species to oxidize organic substrates (Figure 1-1).3b The formation 
of flavin C4a-hydroperoxide was supported with experiments performed by Anderson, in which Anderson 
formed flavin C4a-hydroperoxide by pulse radiolysis to an aerated solutions of riboflavin.5 Flavin-dependent 
monooxygenases catalyze various oxidation reactions of substrates such as hydroxylation, 
Baeyer-Villiger-type oxidation, sulfoxidation, epoxidation, and halogenation.3a Inspired by the high 
reactivity, flavins have been utilized to develop catalytic systems, which performed oxidation reactions of 
organic molecules with dioxygen or hydrogen peroxide as the sacrificial oxidant.6-11 
On the other hand, quinoproteins have been known to perform substrate oxidation reactions without 
activating dioxygen. Quinoproteins have quinone molecules such as pyrroloquinolinequinone 
(4,5-dihydro-4,5-dioxo-1H-pyrrolo-[2,3-f]quinoline-2,7,9-tricarboxylic acid, PQQ), cysteine 
tryptophylquinone (CTQ), tryptophan tryptophylquinone (TTQ), topaquinone (TPQ), and lysine 
tyrosylquinone (LTQ), which behave as cofactors or a part of the protein chain (Figure 1-1).12 Organic 
substrates oxidized by quinoproteins in biological systems include alcohols, amines, and sugars; however, 
apart from PQQ-dependent enzymes, most of all quinoproteins oxidize primary amines as the main 
substrates to obtain corresponding aldehydes in biological systems.12a The reaction mechanism of the 
substrate oxidation with quinoproteins is direct oxidation with the quinone molecule.12 The reduced quinones 
derived from the substrate oxidation are reoxidized by a heme cofactor in the quinoprotein, by a heme-iron 
enzyme, or by a copper enzyme, and thus, a dioxygen molecule is not required for substrate oxidation 
reactions by quinoproteins.12 
 
1–2. PQQ, a Heteroaromatic Coenzyme 
In contrast to other quinone cofactors, PQQ is known for its high reactivity to oxidize alcohols and 
sugars.12a PQQ was found by Hauge in 1964 from soluble PQQ-glucose dehydrogenase as the first 
quinoprotein cofactor.13 The discovery of PQQ was not only the start of quinoprotein chemistry but also the 
third report of redox-active coenzymes following nicotinamide and flavin.14 As another example of enzymes 
containing PQQ, methanol dehydrogenase in methylotrophs has been reported,15,16 which can oxidize 
methanol to formaldehyde.12i To utilize the high reactivity of PQQ-dependent enzymes, various 
investigations aiming for its practical applications have been performed, such as sensors of glucose, which 
detected electronic currents generated by oxidation of glucose with PQQ-dependent quinoproteins.17 On the 
basis of crystal structures, quinoproteins containing PQQ was revealed to form a PQQ-calcium ion complex 
at the active center and use the PQQ-calcium ion complex to oxidize substrates.12a 
Salisbury and co-workers succeeded in explicit determination of the X-ray single-crystal structure of an 
acetone-adduct of PQQ, which was extracted from Pseudomonas TP1, in 1979.18 From the structural analysis 
  3  
and spectroscopic findings reported by Duine and co-workers,19 the structure of PQQ was determined as a 
quinoline-quinone derivative having a fused pyrrole ring at the C-C bond between C5 and C6 of the 
quinoline ring, and three carboxyl groups are substituted at the 2, 7 and 9 positions of the 
pyrrolo-quinoline-quinone structure. 
In 1981, Corey and co-workers reported a total synthesis of PQQ and its methyl ester (PQQTME).20 Since 
then, investigation of PQQ molecules outside of enzymes became possible,21 which had been unavailable 
because of difficulty in extraction of PQQ itself from living animals or plants due to its high reactivity. 
However, PQQ itself is a weak oxidant with the first reduction potential at –0.53 V vs SCE (for PQQTME in 
MeCN) in the absence of the Ca2+ ion.21j Besides, methanol dehydrogenase catalytically oxidizes methanol, 
which cannot be oxidized even by DDQ with higher electron-acceptability (+0.51 V vs SCE),22 by virtue of 
Figure 1-2. (A) Crystal Structure of methanol dehydrogenase, and (B) a magnified figure around the active center.15c 
 
 
Figure 1-3. Proposed mechanisms for the oxidation reaction by methanol dehydrogenase; (A) "addition-elimination mechanism" 
and (B) hydride-transfer mechanism (extracted from Ref. 12a). 
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the activation of the cofactor through Ca2+ binding and proton uptake by an aspartate residue of the protein 
framework.15a,15c,23 
For the oxidation reactions with PQQ, "addition-elimination mechanism" has been proposed on the basis 
of kinetic analyses of the substrate oxidation (Figure 1-3).16a In the addition-elimination mechanism, a 
substrate attacks a carbonyl carbon of PQQ, which is activated by a Lewis acid such as a calcium ion and 
also by strong electronegativity of the nitrogen atom in the pyridine ring of PQQ, and resultantly the 
substrate and PQQ form an intermediate. Theoretical calculations by Toscano’s group also support the 
addition-elimination mechanism.24 On the other hand, hydride-transfer mechanism also has been proposed 
on the basis of a crystallographic high-resolution structure of methanol dehydrogenase from Methylophilus 
methylotrophus and theoretical investigations into the structure of the reduced PQQ, which was suggested to 
be included in the enzyme used for the X-ray analysis (Figure 1-3).12f, 25, 26 Bruice et al. reported that 
methanol dehydrogenase contained a reduced PQQ derivative in the keto form on the basis of the 
high-resolution structure (Figure 1-3B), and also proposed that the reduced PQQ in the keto form could be 
generated only in the hydride-transfer mechanism.25 As described above, the reaction mechanism of substrate 
oxidation with PQQ still remains controversial. 
Oxidation reactions of biologically important molecules, such as thiols, amines, amino acids, and aldoses, 
with use of PQQ outside of enzymatic environments, have been reported since 1984;21a-f however, oxidation 
of alcohols with PQQ was hard to be achieved. Catalytic methanol oxidation using a synthetic PQQ 
derivative was first achieved by Itoh and co-workers in 1997.21g-i Addition of a calcium ion and DBU (= 
1,8-diazabicyclo[5.4.0]undec-7-ene) as a strong base into a PQQTME solution in methanol, ethanol, 
1-propanol, or 2-propanol induced oxidation reactions of the solvent molecules to give corresponding 
aldehydes or ketone.21h In this reaction, dioxygen was used as a sacrificial oxidant. As one of the reasons 
why PQQTME could oxidize methanol, effects of calcium ion was proposed as mentioned above; i.e., the 
PQQTME-Ca2+ complex shows much higher reduction potential at 0.0 V vs SCE in MeCN than that of free 
Figure 1-4. Crystal structures of PQQTME metal-complexes: (A) [CuII(PQQ4–)(terpy)2]27c and (B) [CuI(PQQTME)(PPh3)2]+.28 
Phenyl rings of the PPh3 ligands are omitted for clarity in (B). 
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PQQTME (–0.53 V vs SCE in MeCN).21j However, the complexation constant between PQQTME and a 
calcium ion is not so large (K = 1900 M–1) and the acid-base equilibrium between DBU and PQQTME 
interrupts the aiming oxidation reaction, and thus, the observed reaction rate was much small. In fact, under 
Itoh’s conditions, PQQTME spent 65 h to oxidize 14.5 equiv ethanol even in the ethanol solution.21h 
As mentioned above, interaction of PQQ with metal ions can dramatically enhance the reactivity of PQQ, 
in relation to the association of the calcium ion as demonstrated in the substrate oxidation; however, only a 
few researches on PQQ-transition-metal complexes have been reported so far, and the reported researches 
focused on the X-ray single crystal analyses of the complexes and no attention has been paid to the impact of 
coordination of PQQ derivatives to transition-metal ions on their redox properties and electronic structures 
(Figure 1-4).27, 28 
 
1–3 Pterin: A Dioxygen Activator in Nature 
Pterins are also heteroaromatic coenzymes and known to activate a dioxygen molecule at the active sites 
in metalloenzymes (Figure 1-5). Through the dioxygen activation, organic substrates such as aromatic 
molecules and phenol derivatives are oxidized by, for example, tryptophan hydroxylase,29 phenylalanine 
hydroxylase,30 and tyrosine hydroxylase,31 which involve tetrahydropterin as the cofactor. Tetrahydropterins 
in the tetrahydropterin-dependent hydroxylases exist in the vicinity of an iron center, and the reaction of 
dioxygen with tetrahydrobiopterin has been proposed to produce a metal-peroxo species, a 4a-pterin-OO- 
iron complex, as precursors of active species (Figure 1-5).32 
Mimicking the oxidation reactions performed by tetrahydropterin-dependent hydroxylases should be a 
powerful strategy for development of artificial oxidation systems for organic compounds, because of its high 
 
Figure 1-5. (A) Structure of pterins, and (B) a proposed reaction mechanism in the substrate oxidation at the active center of 
phenylalanine hydroxylase.32-35 
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oxidation power to oxidize aromatic C-H bonds and high selectivity without oxidizing functional groups of 
substrates, which are more prone to oxidation reactions, such as amino groups.32 However, the active species 
of the oxidation reactions have never been detected nor isolated yet due to its instability, and the artificial 
models also have never been reported. Due to the lack of information on the structure of the active species, 
the mechanism of the oxidation reactions by tetrahydrobiopterin-dependent hydroxylases has not been well 
elucidated in spite of intensive efforts,33 and applications of pterins to oxidation reactions have yet to be 
achieved. 
Based on efforts to shed light on the mechanism of substrate oxidation performed by tetrahydropterin- 
dependent hydroxylases in nature, it is revealed that the tetrahydropterin at the vicinity of an iron center 
directly reacts with a dioxygen molecule at the 4a-position to form 4a-hydroperoxy-dihydropterin (Figure 
1-5).33 However, the subsequent reaction of the obtained 4a-hydroperoxydihydropterin remains controversial, 
and there are three hypotheses (Figure 1-5): (1) 4a-hydroperoxy-dihydropterin directly reacts with an organic 
substrate to give an alcohol as the product and 4a-hydroxydihydropterin,34 (2) 4a-hydroperoxy-dihydropterin 
reacts with the iron center to form the pterin-OO-iron complex, and then, the iron-peroxo species oxidizes 
substrates,32 and (3) the iron-peroxo species are converted to iron(IV)-oxo species as active species,35 which 
are regarded as important oxidants in biological systems as mentioned in the next section of this thesis. 
 
1–4 Proton-Coupled Electron Transfer (PCET) 
As mentioned above, various oxidation enzymes oxidize organic substrates in biological systems; i.e. the 
enzymes can perform the oxidation reactions at a body temperature under mild conditions in spite of low 
reactivity of the C–H bonds in organic substrates. In fact, oxidation of C–H bonds of organic compounds is 
very difficult to be achieved in artificial systems due to their high oxidation potentials (> 2 V vs SCE)36 and 
large bond-dissociation energies (BDE). To oxidize organic substrates sufficiently under mild conditions, the 
oxidation enzymes in biological systems adopt PCET as an energetically feasible pathway.37 In PCET 
reactions, the oxidants obtain not only electron(s) but also proton(s) from substrates to give a neutral radical 
product. The thermal stabilities of the products give positive driving forces in the oxidation reactions to 
make it possible to promote the reactions in spite of the high oxidation potentials and large BDEs of organic 
substrates. To learn oxidation of organic substrates from biological systems, PCET reactions have been 
intensively investigated.38-51 
In both natural and artificial systems, high-valent metal-oxo species such as compound I in cytochrome 
P450s are regarded as one of the most powerful oxidants, which oxidize C-H bonds of aliphatic substrates 
through a PCET mechanism. In the formation process of compound I, the iron(II)-porphyrin react with O2 to 
form iron(III)-porphyrin-O2•– species, and then, the iron(III)-porphyrin-O2•– receives one electron and one 
proton to give an iron(III)-porphyrin-OOH– species through a PCET mechanism. The iron(III)-porphyrin- 
OOH– species subsequently accepts one proton and releases a water molecule and the metal center formally 
loses two electrons to give compound I (Figure 1-6). Compound I in the catalytic cycle of cytochrome P450s 
mainly oxidizes C-H bonds of organic substrates to give alcohols, and also oxidizes C=C bonds including 
that of benzene to give epoxide species (Figure 1-6).1 Due to its splendid oxidation reactivity to oxidize even 
benzene, compound I has attracted considerable attention, and the mechanistic insights into the PCET 
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oxidation of C-H bonds have been intensively investigated with use of high-valent metal-oxo complexes.43-51 
In PCET oxidation reactions, both of basicity and electron-acceptability of oxidants are important; because 
PCET oxidants receive not only electron(s) but also proton(s) from substrates. However, determination of 
basicity and electron-acceptability of high-valent metal-oxo species are generally difficult. The lack of 
knowledge on such characteristics of oxidants interrupts entire understanding of PCET chemistry in C-H 
oxidation reactions, especially in correlation among electron- and proton-acceptability and reactivity of 
oxidants. 
 
1–5 Ruthenium(II)-Polypyridyl Units as Platforms of Heteroaromatic Coenzymes 
As mentioned above, to explore the reactivity of heteroaromatic coenzymes, achievement of reversible 
redox behaviors outside of enzymatic environments are very important. However, the heteroaromatic 
coenzymes generally form unstable species upon the redox processes in vitro, as expected for organic 
molecules. However, the problems on the reduction of stable fully-oxidized forms of heteroaromatic 
coenzymes to afford unstable species can be solved by coordination of the coenzymes to transition-metal 
ions. In transition-metal-coenzyme complexes, the positive charge of the coordinated metal center can exert 
higher electron-acceptability on the coordinating coenzyme, and resultantly suppress decomposition of the 
unstable reduced coenzymes. The coordination to a transition-metal center also can afford new functions to 
coenzymes, such as photochromic behaviors52 and oxidation abilities of organic substrates through a PCET 
mechanism.53 Along this line, many transition-metal complexes of flavin,54, 55 alloxazine,56 and pterin57 have 
been synthesized and redox behaviors of the complexes have been well investigated. 
Kojima and coworkers also have reported the redox behaviors of ruthenium(II)-TPA-heteroaromatic 
 
Figure 1-6. Formation process of compound I (A) and substrate oxidation with the compound I in nature (B).1 
  8  
coenzyme complexes; for example, a ruthenium-TPA complex having deprotonated N,N-dimethyl-6,7- 
dimethylpterin (dmdmp) as a ligand showed a reversible reduction behavior of the pterin ligand, which 
allowed detailed characterization of 1e–-reduced pterin species.58 Such a 1e–-reduced species is hard to be 
obtained and handled with use of free pterin molecules, since the free pterin molecules exhibit irreversible 
redox behavior.58 In addition, the ruthenium(III)-TPA-pterin complex, formed with oxidation of the 
corresponding ruthenium(II) complex by an FeIII complex as an oxidant, showed substrate oxidation 
reactivity through a PCET mechanism.53 For example, the ruthenium(III)-pterin complex caught phenols at 
the amino group of the deprotonated 6,7-dimethylpterin (dmp) ligand through hydrogen bonding, and then, 
one electron and one proton were transferred from the phenol molecule to the pterin ligand and ruthenium 
center, respectively, to afford the corresponding phenoxyl radical (Figure 1-7A).53 
A ruthenium(II)-TPA-complex of alloxazine, a derivative of flavin, has been also reported, in which the 
ruthenium(II) center is bound to the two nitrogen atoms of the alloxazine ligand.59 The 1,10-coordination in 
the alloxazine complex allows the alloxazine ligand to behave as a hydrogen-bonding acceptor at the 2-O, 
3-NH, and 4-O sites (Figure 7B). Upon addition of 2,6-bis(acetamido)pyridine into a solution of the 
ruthenium-TPA-alloxazine complex, a 1:1 adduct was formed as confirmed by spectroscopic observations 
and X-ray crystallographic analysis.59 The adduct formation caused a positive shift of the redox potentials of 
the alloxazine ligand and also induced changes in the electronic structure of the 1e–-reduced species.59 The 
ruthenium(II)-TPA-pterin complex also forms a 1:1 adduct with guanine and thymine through hydrogen 
bonding. In the case of guanine, the ruthenium(II)-bound dmdmp– ligand forms three-point complementary 
hydrogen-bonding adduct to exert a positive shift of the reduction potential of the pterin ligand by 300 mV.60 
 
1–6 Purpose of This Research 
As mentioned above, developments of novel functions with ruthenium-heteroatomatic coenzyme 
 
Figure 1-7. Functions of coenzymes derived from coordination to a ruthenium-TPA unit: (A) PCET oxidation of phenol,53 (B) 
hydorogen bonding of a ruthenium-TPA-alloxazine complex with 2,6-bis(acetamido)pyridine.59 
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complexes such as substrate oxidation have been successful so far,46a,59,60 and thus, the author expected that 
the ruthenium-polypyridyl unit was a useful platform also for researches on PQQ. Additionally, the 
formation and detection of pterin-OO-metal species, which is a plausible candidate for the active species in 
pterin-dependent hydroxylases, has yet to be achieved in spite of its importance for gaining mechanistic 
insights into substrate oxidation reactions performed by pterin-dependent oxidation enzymes in nature. 
Therefore, the author has synthesized PQQ- and pterin-complexes, coordinating to ruthenium- or 
rhodium-polypyridyl units, and investigated their redox properties for development of their novel functions 
on the basis of detailed characterization of those complexes using spectroscopic, electrochemical, and 
crystallographic methods. 
In Chapter 2, the author describes synthesis and characterization of two ruthenium-silver-terpy-PQQ 
complexes; their properties have been investigated in detail to clarify the electronic effect of coordination of 
PQQ to transition-metal ions. 
In Chapter 3, synthesis and characterization of ruthenium(II)- and rhodium(III)-pterin complexes toward 
the formation of a pterin-OO-metal species as the final goal. MeBPA (= 
N-methyl-N,N-bis(pyridylmethyl)amine) and TPMOM (= tris(2-pyridyl)-methoxy-methane) were employed 
herein as tridentate ligands to provide a vacant coordination site at the metal centers for coordination of the 
terminal oxygen of a pterin-OO– ligand. Since ruthenium(II) and rhodium(III) ions have similar electronic 
structures of d6-low spin state, and thus, formation of stable complexes with pterin can be expected. 
In Chapter 4, the author describes detailed mechanistic insights into C-H oxidation of organic substrates 
by two ruthenium(III)-pterin complexes on the basis of kinetic analysis. The author focuses on the impact of 
the electron-acceptability of the ruthenium center and the proton-acceptability of the pterin ligand on the 
PCET oxidation of C-H bonds. Herein, the author has clarified that the electron- and proton-acceptability of 
the ruthenium(III)-pterin complexes control the arrangements of the oxidants and the substrates in the 
transition states of the oxidation reactions. 
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Chapter 2 Syntheses and Characterizations of Ruthenium(II)-PQQTME-terpy Complexes 
 
2–1 Introduction 
As described in Section 1-2 in Chapter 1, PQQ is a redox-active heteroaromatic coenzyme, which has 
been first found by Hauge in a glucose dehydrogenase of bacterium anitratum1 as the third redox-active 
coenzyme, after the discovery of nicotinamide and flavins. The biosynthesis of PQQ is achieved using a 
peptide precursor containing glutamic acid and tyrosine residues.2 PQQ catalytically oxidizes glucose and 
alcohols at the active sites of quinoproteins as key steps of biological metabolic reactions, and the resultant 
reduced form of PQQ is reoxidized by cytochrome c or azurin through electron transfer.3-5 Because of the 
facts that the catalytic efficiency of PQQ in its substrate oxidation is quite high and PQQ can utilize 
molecular oxygen as a sacrificial oxidant, exploration of the reaction mechanism for the substrate oxidation 
by PQQ has attracted considerable attention.6-9 An X-ray crystallographic analysis of quinoproteins having 
PQQ as a cofactor shows that the PQQ cofactor is strongly bound to a calcium ion in a tridentate fashion 
through 5-oxo-O, 6-pyidine-N, and 7-carboxylate-O atoms of PQQ (Figure 2-1A).10-12 
Anthony and Richardson have demonstrated that the Ca2+ ion is essential for oxidation of the substrates, 
on the basis of the experiments with use of a mutated methanol dehydrogenase lacking the Ca2+ ion.13 In 
addition, Itoh and co-workers have performed the kinetic analyses on oxidation reactions catalyzed by PQQ 
derivatives to reveal the roles of the Ca2+ ion.6f-h In consequence, the rate constant of the methanol addition at 
the carbonyl carbon of a trimethyl ester derivative of PQQ (PQQTME) is accelerated by 3300 times in the 
presence of Ca2+ ions relative to that in the absence of Ca2+ ions.6f-h Additionally, oxidation of methanol is 
achieved with addition of a strong base into the methanol solution of PQQTME and Ca2+, despite the fact 
that metal-free PQQ is known to be unable to oxidize methanol in non-enzymatic environments.6f-h As 
 
Figure 2-1. (A) Structure of a Ca2+-bound PQQ. (B) Three potential metal-coordination sites (M, M’, and M”) of PQQ. (C) 
Structure of [RuII(η3-PQQTME)(terpy)]2+ (2). (D) Structure of [{RuII(terpy)(sol)}(µ-PQQTME){AgI(OTf)2}]+ (5, sol = a 
coordinating solvent). 
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another effect of Ca2+ ion, the reduction potential of PQQTME is also positively shifted by ca. 0.57 V in the 
presence of Ca2+ ions.14 
Since PQQ has several potential sites for metal coordination in the structure (Figure 2-1B), PQQ can act 
as a ligand in transition-metal complexes. To elucidate the reactivity of PQQ for substrate oxidation and to 
clarify roles of the coordinated Ca2+ ion in the biological activity of PQQ, several metal complexes of PQQ 
and the derivatives have been synthesized and the redox properties of metal-bound PQQ have been 
investigated.15-18 For instance, a CuI-PQQTME complex exhibited the reduction potential of the PQQ moiety 
at –0.02 V vs SCE in CH2Cl2, which was positively shifted by 0.42 V in comparison with that of free 
PQQTME.17 The properties of metal-PQQ complexes, however, have yet to be well explored, and 
heteronuclear transition-metal complexes of PQQ derivatives had never been reported. Due to the shortage 
of examples in transition-metal complexes of PQQ, it has not been well explored yet how the difference in 
the coordination sites of PQQ in the transition-metal complexes influences the electrochemical properties of 
the PQQ ligand and the reactivity in oxidation reactions. To shed light on the point, the author newly 
synthesized RuII complexes of PQQTME, 2 and 5, and compared their properties. Complex 2 has the ONO 
coordination mode for the RuII coordination, whereas compound 5 coordinates to the RuII center through the 
OO coordination mode at the o-quinone moiety and has an additional AgI ion at the ONO coordination site 
(Figure 2-1C and 2-1D). The author also measured the reduction potentials and compared the electronic 
structures of the PQQTME moieties for 2 and 5. 
 
2–2 Syntheses of Two Ruthenium(II)-Silver(I)-PQQTME-terpy Complexes 
In this work, 2,2’:6’,2’’-terpyridine (terpy) was employed as an auxiliary ligand of a RuII ion, since terpy 
is a strongly π-accepting ligand and thus dπ electrons of the RuII center are donated to the terpy ligand by 
π-back bonding.19 Therefore, the back donation of the dπ electrons of the RuII center to the PQQ ligand 
should be reduced and thus the electron density of the PQQ moiety is expected to be lowered and more 
electron-deficient. PQQTME was synthesized with 4-amino-2-hydroxybenzoic acid as a starting material by 
Scheme 2-1. Syntheses of RuII-AgI-PQQTME and RuII-PQQTME complexes 
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the reported procedure.20-23 RuII-PQQTME complexes used in this study were prepared in good yields from 
PQQTME and [RuII(terpy)(OH2)3](OTf)2, which was prepared by treatment of [RuIIICl3(terpy)] with excess 
amount of AgI(OTf) in H2O (Scheme 2-1).24 The resulting aqueous solution of [RuII(terpy)(OH2)3](OTf)2 was 
filtered, and dried up under vacuum to obtain a mixture of [RuII(terpy)(OH2)3](OTf)2 and excess silver salts. 
The mixture was heated overnight at reflux together with PQQTME in 1,2-dichloroethane, and then, the 
resulting suspension was filtered. The filtrate was slowly concentrated to afford crystals of a 
RuII-AgI-PQQTME hetero-multinuclear complex. Interestingly, the amount of AgI(OTf) used for the 
preparation of [RuII(terpy)(OH2)3](OTf)2 controlled the products of the reaction of PQQTME with 
[RuII(terpy)(OH2)3](OTf)2. Using 4 equiv of AgI(OTf) per ruthenium, a dinuclear complex, 
[(terpy)RuII(µ-PQQTME)AgI(OTf2)](OTf)2 (1), was obtained, whereas usage of 7 equiv of AgI(OTf) per 
ruthenium gave a hexanuclear complex, [{(terpy)(OH2)RuII(µ-PQQTME)- 
AgI(OTf)(µ-OTf)}2{(OTf)AgI(µ-OTf)2AgI(OTf)}] (4). 
The structure of 1 was deduced from the results of the elemental analysis for the solid sample of 1·(OTf), 
the spectroscopic data of 2, and the crystal structure of 3·(PF6)2 (See below). The result of the elemental 
analysis indicates that the solid of 1·(OTf) contains an Ag(OTf)3 unit per a RuII(PQQTME)(terpy) unit. In 
addition, relevance to the crystal structure of 3·(PF6)2, the RuII(terpy) unit of 1 is considered to be 
coordinated to the ONO coordination site of the PQQTME ligand. The solid of 1·(OTf) was dissolved in a 
coordinating solvent such as MeCN to give the mononuclear RuII complex, 2. The purity of 4 was confirmed 
by elemental analysis and the explicit structural determination of 4 was done by X-ray crystallography on a 
single crystal (See below). 
 
2–3 Characterizations of Ruthenium(II)-PQQTME-terpy Complexes 
 
2–3–1 1H NMR Spectrum of 2 
Since complexes 4 and 5 do not have enough solubility in deuterated solvents usually used for 1H NMR 
measurements, or exhibit decomposion after dissolving the complexes, only the 1H NMR spectrum of 2 
could be measured. In the 1H NMR spectrum of 2 in CD3CN (Figure 2-2), the 1H NMR signal of the 
methoxycarbonyl group at the 7’-position of the PQQTME ligand appeared at δ 4.22 ppm (red diamond in 
Figure 2-2B), which was downfield-shifted in comparison with that of free PQQTME (δ 4.00 ppm) due to 
 
Figure 2-2. 1H NMR spectra of PQQTME (A) and 2 (B) in CD3CN at room temperature. 
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the coordination to the RuII ion. A similar downfield shift was also observed for the PQQTME-Ca2+ complex, 
which has a Ca2+ ion at the ONO coordination site of PQQTME,6f and thus, complex 2 probably also has the 
ONO-coordination mode (Figure 2-1C). 
 
2–3–2 ESI-TOF-MS Spectra of the PQQ Complexes 
The ESI-TOF-MS spectrum of 2 in acetonitrile (MeCN) showed peak clusters at m/z = 337.6, 353.6, 
358.1, 707.2 and 738.1. All of those clusters exhibited distribution patterns corresponding to species having 
one ruthenium and no sliver atom (Figure 2-3). The former three peak clusters showed peak separations of 
0.5, whereas those of the latter two of them were 1.0. Hence, complex 1 is assumed to lose the AgI ion to 
give the mononuclear complex 2 upon being dissolved in a coordinating solvent such as MeCN, as shown in 
Scheme 2-1. The peak clusters at m/z = 353.6 and 707.2 were assigned to 2 (calcd. for 
[RuII(η3-PQQTME)(terpy)]2+: m/z = 353.5) and 1e–-reduced species of 2 (calcd. for 
[RuII(η3-PQQTME•–)(terpy)]+: m/z = 707.1), respectively. Thus, complex 2 derived from 1 in MeCN should 
be [Ru(terpy)(PQQTME)]2+, in which both terpy and PQQTME bind to the RuII center as tridentate ligands 
in the meridional geometry as shown in Scheme 2-1. The peak clusters at m/z = 337.6 and 358.1 can be 
ascribed to fragment signals of 2; the former should be derived from the fragment species that complex 2 
loses a methoxy group and one proton from the PQQTME moiety (calcd. for [RuII(PQQTME – H – 
OMe)(terpy)]2+: m/z = 337.5), and the latter can be assigned to the species that 2 loses a methoxy group and 
one proton from the PQQTME moiety and then induces additional coordination of an acetonitrile molecule 
(calcd. for [RuII(PQQTME – H – OMe)(terpy)(MeCN)]2+: m/z =  358.0). The methoxycarbonyl group at the 
7’-position of the PQQTME moiety in 2 is possibly activated by coordination to the RuII center and is apt to 
be cleaved between the oxygen atom of the methoxy group and the carbon atom of the carbonyl group at 
7’-position of the PQQTME moiety during ionization processes for ESI-TOF-MS measurements (Figure. 
2-4). The cleavage gave the fragment showing a signal at m/z = 337.6. In addition, the complex losing the 
methoxy group can be attacked by an acetonitrile molecule from the solvent at the RuII center, to give the 
peak cluster at m/z = 358.0, which has been mentioned above. The mass signal derived from 
acetonitrile-coordinating species was not observed without the loss of the methoxy group of PQQTME in the 
ESI-TOF-MS measurements, suggesting that acetonitrile molecules cannot coordinate to the RuII center of 2 
under mild conditions, even in the acetonitrile solution. The peak cluster at 738.1 was assigned to [2 + 
OMe]+ ion (calcd. for {[RuII(PQQTME- OMe)(terpy)]}+: m/z = 738.1). Since the carbonyl group at the 
5-position of PQQ has high reactivity toward nucleophilic attacks and furthermore the reactivity is enhanced 
 
Figure 2-3. ESI-TOF-MS spectrum of 2 in MeCN and the simulation (upper colored spectra in (B) and (C)). The m/z range: A) 
300-800, B) 330-370, and C) 690-760. 
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by metal coordination in 2, the methoxy group is probably added at the carbonyl carbon of the 5-position of 
the PQQTME moiety during the ionization.6g, 25 
Based on the 1H NMR and mass spectroscopic data (See above), it is concluded that complex 1 loses the 
AgI ion in a coordinating solvent such as MeCN to give complex 2, but no further reaction occurs including 
solvent coordination to the RuII center (Scheme 2-1). 
The ESI-TOF-MS spectrum of 4 in a mixed solvent of MeCN and water (2:3 v/v) gave a peak cluster at 
m/z = 964.95 and the isotope distribution indicates that the detected ion contains both of ruthenium and silver 
atoms (Figure 2-5). The computer simulation enabled the assignment of the peak cluster as 
[(terpy)RuII(PQQTME•–)AgI(OTf)]+ (calcd: m/z = 964.92). The PQQTME ligand was probably reduced to be 
a semiquinone radical form in the course of the ionization. The detection of 
[(terpy)RuII(PQQTME•–)AgI(OTf)]+ in the ESI-TOF-MS measurement of 4 suggests that, in contrast to the 
case of dissolving 1, even after dissolving in MeCN, complex 4 does not lose the silver ion, which is directly 
coordinated to PQQTME ligand, to give a hetero-dinuclear complex, 5 (Scheme 2-1). This difference in the 
stability of AgI coordination can be attributed to the number of coordinating atoms: PQQTME in 1 behaves 
 
Figure 2-4. A proposed reaction mechanism of the cleavage between the oxygen atom of the methoxy group and the carbon atom 
of the carbonyl group at 7’-position of the PQQTME to form a putative ketene (m/z = 337.5) and the subsequent nucleophilic 
attack of a methoxide ion toward the carbonyl group of 5-position of the PQQTME ligand of another molecule to afford the 
methoxide adduct (m/z = 738.1), occurring upon ionization for ESI-TOF-MS measurements. 
 
Figure 2-5. ESI-TOF-MS spectrum of 5 in MeCN-H2O mixed solvent (2:3 v/v); experimental (black, below), simulated for 
[(terpy)Ru(µ-PQQTME)Ag(OTf)] (red, above) 
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as a bidentate ligand to the AgI ion, whereas that in 5 acts as a tridentate one. 
 
2–3–3 DFT Calculations on 2 and 5 
Density functional theory (DFT) calculations were conducted on 2 and 5 to shed light on the geometrical 
and electronic structures. The optimized structure of 2 is shown in Figure 2-6. The bond lengths of Ru-Oq, 
Ru-Oc, and Ru-Np were calculated to be 2.078 Å, 2.189 Å, and 1.975 Å, respectively. The LUMO of 2 was 
revealed to be a π* orbital of the quinone moiety of the PQQTME ligand as shown in Figure 2-7. In 
comparison with the LUMO of 5, there are only slight differences between the LUMOs of 2 and 5 and both 
the LUMOs are π* orbitals of the PQQTME ligand. 
DFT calculations were also conducted on a free PQQTME molecule to discuss π-back bonding from the 
RuII center to PQQTME in 2 through comparison of the lengths of coordinating carbonyl C–O double bond 
between free PQQTME and 2. In optimized structure of free PQQTME, the lengths of the C=O double bonds 
of the two carbonyl groups, which coordinate to the RuII center in 2, are 1.211 Å (quinone) and 1.210 Å 
(ester), respectively. On the other hand, the corresponding lengths in the optimized structure of 2 are 1.262 Å 
(quinone) and 1.257 Å (ester). The difference in the bond lengths indicates the π-back bonding from the RuII 
center to the PQQTME ligand in 2. 
 
2–3–4 Crystal Structure of 3·(PF6)2 
 
Figure 2-7. The frontier orbitals of 2 and 5 calculated at the B3LYP level. HOMO (A) and LUMO (B) of 2, and HOMO (C) and 
LUMO (D) of 5. 
 
Figure 2-6. DFT-optimized structure of 2 at the B3LYP level. Oq, Oc, and Npy denote the Ru-bound quinone oxygen, the 
Ru-bound carbonyl oxygen, and the Ru-bound pyridine nitrogen of the PQQTME ligand, respectively. 
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Slow concentration of a solution of 2 in acetonitrile containing TBAPF6 in the presence of diffused 
CHCl3 vapor gave a green crystal suitable for X-ray crystallography. The crystal contains two independent 
cation parts of [RuII(terpy)(η2-PQQTME)(MeCN)]2+ (3), which exhibits dissociation of the methoxycarbonyl 
group at the 7’ position from the RuII center and has a coordinated acetonitrile molecule to the RuII center 
(Scheme 2-1), and four hexafluorophosphate anions. The structure of one of the cations is depicted in Figure 
2-8 with selected atom labeling. The cation parts are chemically equivalent, except slight structural 
differences caused by the crystal packing. Since the replacement of the methoxycarbonyl group in 2 to an 
MeCN molecule was not observed in the 1H NMR spectra of 2 measured at a few hours later after dissolving 
2 in CD3CN, the author assumed that the substitution slowly occurred during the crystallization taking over 
ten days. 
Here, details of the crystal structure of 3 are discussed using one of the two independent cation parts, 
containing Ru1 atom. The geometry around the RuII ion in 3 is a distorted octahedron having terpy as a 
tridentate ligand and the PQQTME ligand binds to the RuII center as a neutral bidentate ligand, where the 
N(pyridine) and O(quinone) coordinates to the RuII center. An MeCN molecule occupies the last 
coordination site of the RuII center, by substituting the methoxycarbonyl O atom at the 7’-position of the 
PQQTME ligand. The dissociation of the carbonyl O atom should be due to the weak coordination as 
reported for a CuI-PQQTME complex, in which the coordination bond length has been reported to be the 
longest (2.579(4) Å) among other coordination bonds involved.17 As mentioned above, the DFT-optimized 
structure of 2 (Figure 2-5) also showed the longest bond length for Ru-Oc (2.189 Å) to support the possibility 
of the dissociation of the methoxycarbonyl oxygen atom toward the coordination of MeCN, which should 
bind strongly to a RuII center.26 In addition, the longer bond length of the metal-coordinating carbonyl bond 
(C5–O1: 1.27(1) Å) was observed than those of the CuI-PQQTME complex (1.222(8) Å)17 and those of 
natural methanol dehydrogenases (1.24 Å, defined as the semiquinone radical forms).10d This result suggests 
certain contribution of π-back bonding from the dπ orbitals of the RuII center to the π* orbitals of the 
PQQTME moiety, which resides mainly on the quinone moiety including the C=O double bond (Figure 2-7). 
The smaller bond angle of N2–Ru1–N4 (168.4(3)°) relative to that of O1–Ru1–N6 (176.9(3)°) indicates 
steric repulsion between the methoxycarbonyl group at the 7’-position of the PQQTME moiety and the 
 
Figure 2-8. An ORTEP drawing of 3 with selected atom labeling. All the thermal ellipsoids are drawn with 30% probability. 
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coordinating acetonitrile, which results in the lean of the PQQTME ligand to the direction of the O1 side. In 
addition, an intramolecular hydrogen bond was found between N1-H···O7 with 2.61(1) Å for N1···O7 
separation. 
 
2–3–5 Crystal Structure of 4 
The explicit structural determination of 4 was done by X-ray crystallography on a single crystal obtained 
by crystallization from the dichloroethane solution of the reaction mixture (Figure 2-9). Complex 4 involves 
a PQQTME unit as a ligand in the asymmetric unit and the RuII(terpy) moiety coordinated to the 
ortho-quinone moiety of PQQTME. The bond distances between the Ru center and the terpy and PQQTME 
ligands are 1.975(6) Å for Ru-O1, 2.025(6) Å for Ru-O2, 2.059(10) Å for Ru-N3, 1.951(9) Å for Ru-N4, 
2.051(10) Å for Ru-N5, respectively. The distances strongly indicate that the electronic state of the Ru center  
is +2. The last coordination site of the RuII center was occupied by an oxygen atom with the bond distance of 
Ru-O10 (2.081(9) Å), suggesting that the oxygen atom is not a hydroxo but an aqua-ligand.27 An Ag(OTf) 
unit, which was derived from the excessive AgI(OTf) employed to remove the chloride ligands of 
[RuIIICl3(terpy)], was found to bind to the meridional tridentate part (ONO-moiety) of PQQTME. This is the 
first example of a PQQ-bridged heterometallic complex, whose crystal structure has been determined. The 
Ag center resided in a distorted trigonal-bipyramidal coordination environment and the trigonal-equatorial 
plane consisted of two oxygen atoms (O12 and O14) of two OTf– ions and a nitrogen atom (N2) at the 
6-position of the PQQTME ligand and the two axial positions were occupied by two oxygen atoms derived 
from the 5-oxo (O2) and 7’-ester-carbonyl oxo (O5) ligands. The 5-oxo ligand (O2) was shared with both the 
RuII and AgI centers as a bridging ligand. The bond lengths are 2.615(6) Å for Ag1-O2, 2.493(9) Å for 
Ag1-O5, 2.683(13) Å for Ag1-O12, 2.361(10) Å for Ag1-O14, and 2.343(10) Å for Ag1-N2, respectively. 
Comparison of the bond lengths with the reported corresponding value28 allowed the author to conclude that 
 
Figure 2-9. ORTEP drawings of the crystal structure of 4 with selected atom labeling. (A) The whole structure of 4, in which the 
carbon atoms of the terpy ligand, trifluoromethyl groups and uncoordinating oxygen atoms of OTf– ions, and hydrogen atoms 
were omitted for clarity. Each atom is drawn with the thermal ellipsoid at the 30% probability. (B) The hetero-dinuclear unit of 4. 
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the oxidation state of the Ag ion was revealed to be +1. The ion radii of AgI and Ca2+ ions are similar to each 
other, and the bond lengths between the Ag1 ion and the PQQ ligand in 4 were very close to the 
corresponding lengths between a Ca2+ ion and the PQQ cofactor in quino-proteins; for instance, 2.55 Å for 
Ca2+-to-5-oxo, 2.40 Å for Ca2+-to-6-nitrogen, 2.24 Å for Ca2+-to-carboxylate-oxygen, respectively, found in 
a crystal structure of methanol dehydrogenase.12 In addition, two [AgI(OTf)2]– units formed a 
eight-membered ring, which bridged two [(terpy)(OH2)RuII(PQQTME)AgI(OTf)]+ moieties (Figure 2-9 and 
Figure 2-10). In the crystal, the PQQTME ligand was found to interact with another PQQTME ligand of an 
adjacent molecule to form a π-π stacking pair with the inter-plane distance of 3.47 Å (Figure 2-11A and B). 
Concomitantly, the terpy ligand also formed a π-π stacking pair with another terpy ligand in a neighboring 
molecule with the inter-plane distance of 3.42 Å (Figure 2-11C and D). The intermolecular π-π interactions 
hold the crystal packing of 4. 
The crystal structure of 4 exhibits a completely different coordination mode of PQQTME from that in 3; 
complex 4 has one RuII ion at the O(methoxycarbonyl)-N(pyridine)-O(quinone) coordination site and one 
AgI ion at the o-quinone coordination site of the PQQTME moiety (Scheme 2-1). 
 
2–3–6 Electrochemical Measurements to Investigate Electron Acceptability of PQQ Complexes 
Figure 2-11. π-π stacking manners in the crystal structure of 4. A stacking pair of PQQTME ligands (A, B) and that of terpy 
ligands (C, D). 
Figure 2-10. ORTEP diagrams of partial crystal structures of 4. (A) PQQTME and the coordination environments of Ru and Ag1 
centers, and (B) the bridging metallacycle. Each atom is drawn with a thermal ellipsoid at the 30% probability level. 
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Cyclic and differential-pulse voltammograms (CV and DPV, respectively) of 2 and 5 were measured in 
THF containing 0.1 M TBAPF6 as a supporting electrolyte at room temperature under Ar atmosphere. In the 
measurements of 2, the rest potential was found to be +0.77 V vs SCE and complex 2 exhibited a reversible 
reduction wave at +0.28 V vs SCE with a peak separation value (Epc – Epa) of 64 mV (Figure 2-12). On the 
other hand, CV of 5 in THF showed one irreversible reduction wave at Epc = +0.42 V vs SCE, and the 
reduction potential was determined to be +0.50 V vs SCE using the peak potential of DPV, which is higher 
than that of 2 by 0.22 V. The waves can be assigned to 1e– reduction of the quinone moiety of the PQQTME 
ligand in 2 and 5, based on the absorption spectra of chemically reduced 2 (see below), and the DFT 
calculations also suggest that the LUMO of 2 and 5 is a π* molecular orbital of the PQQTME ligand (Figure 
2-7B and 2-7D). The reduction potentials exhibited a larger positive shift from that of free PQQTME (Ered = 
−0.53 V vs SCE in MeCN)14 and even larger than that observed for a mononuclear CuI-PQQTME complex 
(E1/2 = −0.02 V vs SCE),17 because of the high electron acceptability of the RuII-terpy unit. As for the RuII 
center, no redox processes could be observed in the potential window of the MeCN solution of 2 and 5 (up to 
ca. +1.6 V). Since the redox potential of RuII/RuIII couple for [RuII(terpy)2]2+ has been reported to be +1.38 V 
(vs SCE),29 the PQQTME ligand should act as a stronger π-acceptor than terpy in the RuII coordination 
sphere. The difference of the redox potentials between 2 and 5 can be ascribed to the number of metal ions 
binding to the PQQTME ligand and also difference of the coordination modes as depicted in Figure 2-13. 
Complex 2 has one RuII ion at the ONO coordination site of the PQQTME ligand, which is not fully 
conjugated with the quinone moiety that acts as the electron-accepting site for the reduction process. In 
contrast, complex 5 holds two transition metal cations at the quinone moiety, one of which is a AgI ion at the 
ONO coordination site in a monodentate fashion and the other is a RuII ion at the quinone moiety in a 
bidentate mode. DFT calculations indicated that the LUMO levels of 2 (–9.11 eV) was comparable to that of 
 
Figure 2-12. (A) Cyclic and (B) differential-pulse voltammograms of 2 (1.0 mM) and 5 (2.0 mM) in THF containing 0.1 M 
TBAPF6 at room temperature. 
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[RuII(terpy)(PQQTME)(H2O)]2+ (–9.07 eV), which is a model compound of 5 without the [AgI(OTf)2]– unit. 
This result suggests that, without AgI binding, the reduction potential of 5 should be comparable to that of 2, 
in sharp contrast to the fact described above. Note that the OTf– ions bound to AgI should be prone to be 
substituted by THF molecules in the THF solution used for the electrochemical measurements. Therefore, 
the higher reduction potential should be derived from the binding of AgI ion as a Lewis acid to support the 
AgI binding in the proposed structure of 5 as depicted in Scheme 2-1 and Figure 2-13. Thus, we conclude 
that the AgI binding to the ONO moiety of PQQTME has a strong impact on the rise of the reduction 
potential of PQQTME. 
The difference of reversibility in the reduction waves between 2 and 5 also can be explained by difference 
in the coordination modes. Since the RuII ion in 2 is bound at the ONO coordination site of the PQQTME 
ligand, the coordination bonds should be strong because of the tridentate chelation and the strong 
π-acceptability of PQQTME. On the other hand, the RuII ion of 5 is bonded only with the two quinone-O 
atoms in a bidentate mode. Although the 1e– reduction of 5 strengthen σ-donation from the carbonyl oxygen 
atoms of the reduced quinone moiety to the RuII center, the effect should be compensated by reduction of the 
π-acceptability of the quinone moiety. Thus, the effect of this strengthened σ-donation on reversibility of the 
redox process is probably limited. Therefore, the reason for the irreversibility of the reduction wave observed 
for 5 can be ascribed to weakness of the coordination bonds between the Ru(II) center and PQQTME in 5. In 
consequence, the difference in the coordination modes between 2 and 5 causes not only difference in the 
reduction potentials but also that in stability of 1e–-reduced forms of 2 and 5. 
 
2–3–7 UV-Vis Spectra of 2 and 5 to Discuss their Electronic Structures 
Complex 2 dissolved in DMF at –20 °C showed absorption bands at 705, 476, 377, and 338 nm (Figure 
2-14). The first and the third absorption bands can be assigned to MLCT bands from dπ orbitals of the RuII 
ion to the PQQTME ligand (705 and 377 nm), and the second one can be assigned to another MLCT 
transition from the RuII center to the π* orbitals of the terpy ligand (476 nm), based on comparison with 
UV-vis absorption bands of 5 (vide infra). 
UV-Vis spectrum of 5 in DMF at –50 °C showed similar absorption bands to those of 2 at 723, 484, 376, 
and 318 nm (Figure 2-14). Based on the time-dependent density functional theory (Figure 2-15) calculations 
of 5, the first and the third absorption bands can be assigned to MLCT transitions from the RuII center to the 
PQQTME ligand (723 and 376 nm) and the second one is ascribed to another MLCT transition from the RuII 
center to the terpy ligand (484 nm).30 The low-energy MLCT absorption band of the RuII-PQQTME complex 
indicates the highly stabilized π* orbital of the PQQTME ligand. 
 
Figure 2-13. Schematic description of the difference of coordination modes between 2 (A) and 5 (B). 
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Since the absorption band of 2 in cooled DMF at 377 nm is not intense and hard to be separated from other 
overlapped absorption bands, the MLCT absorption bands at longer wavelength around 700 nm was used for 
discussion on the electronic structures of PQQTME in the complexes 2 and 5. The MLCT band due to the 
transition from the RuII center to the PQQTME ligand in 5 around 700 nm (λmax = 723 nm) is red-shifted 
relative to that of 2 (705 nm), and this tendency is consistent with the order of the electron acceptability of 
the PQQTME ligand between complexes 2 and 5. In complex 5, PQQTME coordinates to not only the RuII 
ion but also to the AgI ion, and thus, the PQQTME ligand in 5 has higher electron acceptability (+0.50 V vs 
SCE) than that of 2 (+0.28 V vs SCE) as mentioned above. A higher electron acceptability of PQQTME 
suggests that the PQQTME has a lower LUMO level, and the PQQTME having a lower LUMO level should 
show lower-energy MLCT absorption bands in the UV-Vis spectra. As mentioned in this section, not only 
results of electrochemical measurements but also those of UV-Vis measurements indicate that the metal 
coordination of PQQTME significantly enhances the electron-acceptability of the PQQTME ligand. 
 
2–3–8 Chemical Reduction of 2 
 
Figure 2-15. A TD-DFT calculated spectrum of 5 (solid line), the calculated excitation energies and oscillator strengths (vertical 
lines), and the corresponding orbitals related to each absorption band. The assigned transition occurs from a brown-colored orbital 
to a purple-colored one. Inset: The DFT optimized structure of 5 with an aqua ligand. 
 
Figure 2-14. Absorption spectra of 2 (at –20 °C, green line) and 5 (at –50 °C, blue line) in DMF. 
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To elucidate the characteristics of 1e–-reduced 2, which showed fairly good reversibility in the reduction 
process (Figure 2-12), the absorption spectra of 2 were measured upon addition of decamethylferrocene (Eox 
= –0.08 V vs SCE in MeCN) as a reductant.31 The absorption spectrum of 2 in MeCN at 0 °C under Ar 
atmosphere exhibited a similar spectrum to that of 2 in DMF and showed the absorption maxima at 374, 441, 
and 691 nm. The latter two absorption bands are assigned to the MLCT bands from dπ orbitals of the RuII 
ion to the π* orbitals of the terpy ligand (441 nm) and the PQQTME ligand (691 nm). Upon addition of 1 
equiv of decamethylferrocene into the solution of 2 in MeCN at 0 °C, the MLCT band of the RuII center to 
the terpy ligand, originally observed at 441 nm, was shifted to 475 nm, and the MLCT bands due to CT from 
the RuII center to the PQQTME ligand at 691 nm disappeared, with showing isosbestic points at 405, 458, 
and 584 nm (Figure 2-16A). Additionally, the original spectrum was recovered by adding 
tris(4-bromophenyl)-aminium hexachloroantimonate as a 1e– oxidant to the solution of 1e–-reduced 2 (Figure 
2-16B), indicating that the redox process is highly reversible as expected from the CV of 2 (Figure 2-12). It 
is assumed that the disappearance of the longer MLCT band should be caused by large rise in the energy 
level of the LUMO on the 1e–-reduced PQQTME ligand. It is also suggested that the 1e– reduction of the 
PQQTME moiety destabilizes the dπ level of the RuII center to cause the red shift of the MLCT band from 
the RuII center to the terpy ligand. 
 
2–3–9 ESR Measurements on Chemically Reduced 2 and 5 
The electronic structure of the 1e–-reduced species of 2 was investigated by ESR sceptroscopy at 95 K in 
the frozen MeCN solution, which was prepared by treatment of 2 with decamethylferrocene as a reductant 
(Figure 2-17A). In the ESR spectrum, a signal was observed at g = 2.006, indicating the formation of a 
RuII-bound organic radical, that is, PQQTME•–. Kaim and co-workers have reported that the ESR spectrum 
of a 1e–-reduced RuII-PQQ complex.17,18 The 1e–-reduced 2 showed a similar ESR signal to that of the 
Kaim’s complex and the ESR spectrum of 1e–-reduced 2 was also very similar to that of 1e–-reduced 5 in 
frozen THF, also formed by the reaction of 5 with decamethylferrocene as a reductant (Figure 2-17B). Thus, 
it is concluded that the 1e– reductions of 2 and 5 afford the identical electronic structure, that is, a 
semiquinone radical anion state of the RuII-bound PQQTME ligand. 
DFT calculations were performed on 1e–-reduced 2 to elucidate the electronic structure of the reduced 
species and the redox properties of the PQQTME ligand in 2. The calculations suggest that the SOMO of 1e–
 
Figure 2-16. UV–vis spectral changes of 2 upon reduction in MeCN at 0 °C. (A) Titration of DecFc (0 (green) – 1 eq (blue)) and 
(B) re-oxidation with addition of tris(4-bromophenyl)aminium hexachloroantimonate (0 (blue) – 1 eq (red)). 
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-reduced 2 shows π* character and delocalizes over the PQQTME moiety (Figure 2-18A). This result 
indicates that 1e– reduction of 2 occurs on the PQQTME ligand similarly to that of 5 (Figure 2-18B). The 
similarity of the SOMOs of 2 and 5 is well matched to the results of the ESR measurements of 1e–-reduced 2 
and 5, in which the signals observed are very similar to each other. These results indicate that the difference 
in coordination modes between 2 and 5 does not affect the electronic structures of the PQQTME•– ligand, 
despite the fact that it affects the stability of the 1e–-reduced species and the electron acceptability, that is, 
redox potentials of the PQQTME ligand. 
 
2–4 Reactivity of Ruthenium(II)-PQQTME-terpy Complexes 
Oxidation reactivity of 2 was investigated in MeCN with use of organic substrates, known to be oxidized 
by free PQQTME. Benzylamine was added into a green solution of 2 in CD3CN, and the color of the 
solution changed immediately to red-brown. However, in the 1H NMR measurements of the red solution, 
only signals derived from benzylamine were observed and signals of 2 or other PQQ species did not appear 
 
Figure 2-18. DFT-calculated SOMO of 1e– reduced 2 (A) and 5 (B). 
 
Figure 2-17. (A) An ESR spectrum of 1e–-reduced 2, generated by the chemical reduction of 2 with 1 equiv decamethylferrocene 
in frozen MeCN at 95 K. (B) An ESR spectrum of 1e–-reduced 5, generated by the chemical reduction of 5 with 1 equiv 
decamethylferrocene in frozen THF containing 0.1 M TBAPF6 at 140 K. 
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even in the paramagnetic region (Figure 2-19), and the signals completely agreed with those of the authentic 
sample of benzylamine in CD3CN. Hence, under the conditions, it was concluded that only decomposition of 
2 occurred and oxidation of benzylamine with 2 was not achieved. 
When a large excess amount of ethanol (thousands eq) was added to a CD3CN solution of 2, no change 
was observed in the color of the solution and the 1H NMR signals of 2 were intact after stirring the solution 
for 48 h at room temperature (Figure 2-20). PQQ has been known to form an adduct with an alcohol such as 
methanol and ethanol; in the adduct the C=O moiety at the 5-position of PQQ undergoes a nucleophilic 
attack of the alcoholic OH group to form a covalent C-O bond as depicted in Figure 2-4. Since the free 
PQQTME shows a very small association constant (K = 0.20 M–1) in the adduct formation with ethanol,6g, 25 
it may be reasonable that the adduct formation between 2 and ethanol is not observed. In the 
PQQTME-calcium complexes, the necessity of the presence of a strong base is known for oxidizing alcohols, 
and thus DBU (= 1,8-diazabicyclo[5.4.0]undec-7-ene) was added as a strong base into the CD3CN solution 
of 2 and ethanol; however, only upfield shifts of the 1H NMR signals of 2 was observed due to deprotonation 
of its PQQTME ligand from the pyrrolic N-H moiety, and no change appeared in the 1H NMR signals of 
ethanol (Figure 2-21). Even after a long period of time, the signals of ethanol did not change and the only 
change observed was derived from slow decomposition of deprotonated 2. In attempts at the photochemical 
 
Figure 2-19. 1H NMR spectra of benzylamine (A) and a reaction mixture with 2 and benzylamine (B) in CD3CN. 
 
Figure 2-20. 1H NMR spectra of 2 in CD3CN before (A) and after addition of EtOH (~9000 equiv) (B). 
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oxidation reactions with 2 under photoirradiation with use of 4-methoxybenzyl alcohol as a substrate, 
4-methoxybenzaldehyde was detected as the oxidation product; based on the amounts of the product and 
complex 2, the reaction probably proceeded catalytically. However, free PQQTME and 
[RuII(terpy)(MeCN)3]2+ were observed in the 1H NMR and ESI-TOF-MS measurements of the solution after 
the reaction, and most of 2 decomposed due to photoirradiation for the long time. Hence, it is plausible that 
the substrate oxidation observed is mainly conducted by the free PQQTME, which is photochemically 
released from 2. As described above, complex 2 has never shown clear reactivity for oxidation reactions of 
organic substrates to date. 
On the other hand, slow oxidation reaction of ethanol proceeded, when DBU and ethanol were added into 
an CD3CN solution containing free PQQTME and [RuII(terpy)(MeCN)3]2+ obtained from thermal 
decomposition of 2. In the reaction, a larger amount of acetaldehyde as the oxidation product was observed 
by 1H NMR measurements (Figure 2-22) in comparison with the initial amount of 2, indicating that free 
PQQTME generated by decomposition of 2 is capable of oxidizing alcohols catalytically even under 
conditions where substrate oxidation with 2 is not observed. Therefore, the coordination of PQQTME to a 
ruthenium(II) ion deprives the PQQTME in 2 of reactivity in oxidation of organic substrates. 
In light of the results of kinetic analyses reported by Itoh and co-workers,6 it is assumed that substrate 
oxidation with PQQ does not proceed through the hydride-transfer mechanism, but through the 
addition-elimination mechanism, and electrophilicity of the PQQ carbonyl group is necessary for substrate 
oxidation. As an alternative oxidation reaction pathway, PCET reaction can be considered;32 however, the 
electron-acceptability of 2 (+0.28 V vs SCE) is too low to oxidize organic substrates even through a PCET 
mechanism. Hence there are two possible explanations why the oxidation reactivity of PQQ is lost by its 
coordination to a ruthenium(II) ion. One is the steric hindrance caused by the terpy ligand to hamper the 
nucleophilic attacks of substrates on the carbonyl groups of PQQTME. The adduct formation between free 
 
Figure 2-21. 1H NMR spectra of the mixture of 2 and EtOH (~6000 eq) in CD3CN before (A) and after addition of DBU (~1000 
equiv) (B). 
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PQQTME and substrates is not so favorable; for example, the largest K value reported so far is 3.6 M–1 for 
the adduct between the PQQTME-calcium complex and methanol.6g Due to the very small K values, the 
substrate oxidation by PQQTME should be essentially very slow. Thus, the steric hindrance caused by the 
terpy ligand around the carbonyl groups at the 5-position of the PQQTME ligand completely prevents the 
formation of a covalently bound PQQTME-alcohol adduct (Figure 2-23). Another possible explanation for 
the inertness of 2 in substrate oxidation is the effect of π-back donation from the ruthenium(II) center to the 
PQQTME ligand. The π-back donation from the ruthenium(II) center to the π* orbital on the carbonyl bond 
reduces the electrophilicity of the carbonyl group, and thus, nucleophilic addition of substrates to the 
carbonyl group of PQQTME becomes difficult (Figure 2-24). This effect can prevent oxidation reactions by 
the PQQTME ligand through the addition-elimination mechanism. It is assumed that the second hypothesis 
 
Figure 2-22. 1H NMR spectra of CD3CN solution containing free PQQTME and [RuII(terpy)(MeCN)3]2+ obtained from thermal 
decomposition of 2 (A), after addition of EtOH (~3400 eq) into the solution in A (B), and 6 h later after subsequent addition of 
DBU (~1000 eq) to the solution in B (C). 
 
Figure 2-23. Steric hindrance to prevent adduct formation between alcohol and 2 caused by the terpy ligand around the carbonyl 
groups at the 5-position of the PQQTME ligand in 2.  
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is more rational, because Suzuki and coworkers have reported that their copper(II)-PQQ-terpy complex can 
oxidize benzylamine catalytically;15b this promotion of the oxidation is probably due to the fact that a 
copper(II) ion is much less effective in π-back donation to π-acidic ligands than a ruthenium(II) ion. 
To a solution of 5 in THF containing 0.1 M TBAPF6 was added methanol, and then MLCT band of 5 
disappeared in the UV-Vis measurement. However, the difficulty in synthesis of 4 prevents the author from 
detailed investigation into the color change, thus the reactivity of 5 with methanol has yet to be clarified. 
 
2–5 Conclusion 
In this Chapter, the author has described the synthesis and characterization of RuII-PQQTME complexes. 
In complexes 1, 2, and 3, the RuII ion is bound to the PQQTME ligand through the ONO coordination site, 
whereas the RuII ion coordinates to the o-quinone moiety of the PQQTME ligand in 4 and 5. The PQQTME 
ligand in 2 and 5 exhibited higher reduction potentials in comparison with those of PQQ cofactors in natural 
enzymes and also those of reported metal-PQQ complexes, reflecting the high electron-acceptability of the 
RuII-terpy unit. The difference in coordination modes between 2 and 5 causes differences of the physical 
properties between the complexes. For instance, the difference in the coordination mode causes the 
difference in stability of the reduced form of 2 and 5. In addition, the PQQTME moiety in 5 shows a higher 
reduction potential than that in 2, despite having the similar electronic structures in their 1e–-reduced forms. 
The difference in the reduction potentials has been revealed to be mainly derived from the AgI-ion binding to 
the tridentate ONO-bay moiety of the PQQTME ligand in 5 as a Lewis acid. This finding is fully consistent 
with the Ca2+-binding to the same position in the natural enzymes such as methanol dehydrogenases. 
Unfortunately, complex 2 did not show any reactivity in oxidation of organic substrates such as methanol. 
 
Figure 2-24. (A) π-back donation from ruthenium(II) center to π* orbital on the carbonyl bond of PQQTME ligand and (B) 
weakened double bond character of the carbonyl bond by the π-back donation from ruthenium(II) center. 
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Chapter 3 Syntheses and Characterization of Ruthenium(II)- and  
Rhodium(III)-Pterin Complexes Having Polypyridyl Ligands 
 
3–1 Introduction 
Pterins (Figure 3-1A) are redox-active heteroaromatic coenzymes and they perform several biological 
functions including catalytically active sites in substrate oxidation reactions with use of dioxygen as a 
sacrificial oxidant.1 In the oxidation reactions, tetrahydropterin, which is 4e–-reduced form of a pterin, at the 
vicinity of a metal center reacts with dioxygen and a substrate to produce 4a-hydroxy-dihydropterin and 
oxygenated products of the substrate (Figure 3-1B). In the course of the reaction, dioxygen is 4e–-reduced, 
and the tetrahydropterin and the substrate are 2e–-oxidized, respectively. The oxidized pterin, 
 
Figure 3-1. Structure of a pterin (A), and one of the proposed reaction mechanisms in the substrate oxidation at the active center of 
phenylalanine hydroxylase (B).1 
 
Figure 3-2. A plausible catalytic cycle of substrate oxidation with tetrahydropterin as the catalyst.1 
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4a-hydroxydihydropterin, is dehydrated by enzymes such as pterin-4-α-carbinolamine dehydratase2 to form a 
dihydropterin. The generated dihydropterin is directly reduced to regenerate the tetrahydropterin by 
dihydropterin reductase,3 or tautomerized to 7,8-dihydropterin. 7,8-Dihydropterin obtained is reduced by 
dihydrofolate reductase to regenerate the tetrahydropterin (Figure 3-2).4 
In tetrahydropterin-dependent hydroxylases such as tryptophan hydroxylase,5 phenylalanine 
hydroxylase,6 tyrosine hydroxylase,7,8 tetrahydropterin in combination with transition-metal ions catalyzes 
oxidation of aliphatic and aromatic C-H bonds to form C-O bonds, using dioxygen as a sacrificial oxidant. 
The oxidation reactions catalyzed by tetrahydropterins are frequently used to obtain vital molecules such as 
serotonin,5 tyrosine,6 L-DOPA (= (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid),7 and so on.8 Despite 
the fact that the oxidation of non-activated aromatic C-H bonds to C-O bonds is very difficult to achieve in 
artificial systems, the enzymes perform the oxidation with splendid efficiency, selectivity, and turnover 
numbers under mild conditions. In the oxidation reactions performed by both heme and non-heme 
phenylalanine hydroxylase, a pterin-OO-iron complex, in which a peroxide linkage bridges between the 4a 
position of the pterin and an iron center, is proposed as the most plausible candidate of the active species for 
the oxidation reactions based on the detection of 4a-hydroxopterin.9 The reaction mechanisms of 
pterin-dependent hydroxylation have yet to be fully elucidated, due to the lack of knowledge on the 
intermediates. Thus, applications of the oxidation power of pterin-dependent hydroxylases to artificial 
catalytic oxidation systems have been hardly achieved in spite of its splendid reactivity. 
In this chapter, the author describes protonation and PCET processes of ruthenium(II) and rhodium(III) 
complexes of a pterin derivative (Hdmdmp = 2-(N,N-dimethyl)-6,7- dimethylpterin), toward the detection 
and isolation of pterin-OO-metal species. For this purpose, 1e– reduction of protonated pterin complexes and 
subsequent addition of an O2•– salt were examined (Scheme 3-1). 
 
3–2 Syntheses of Precursor Complexes and Pterin Complexes 
Here, metal-pyridylamine units were adopted as platforms of the deprotonated dmdmp– ligand, because 
Kojima and coworkers reported that a ruthenium(II)-TPA-pterin complex has been demonstrated to exhibit 
high stability upon 1e–-reduction of the pterin ligand and clear PCET processes.10 The TPA ligand, however, 
does not allow the metal center to form a tridentate peroxo-pterin ligand by a reaction of a bidentate pterin 
ligand with O2 or its reduced species; because all of the coordination sites around the six-coordinate metal 
center are occupied by the tetradentate TPA and the bidentate pterin ligands. Hence, two tridentate 
polypyridyl ligands, MeBPA (= N-methyl-N,N-bis(pyridylmethyl)amine) and TPMOM (= 
tris(2-pyridyl)-methoxy-methane) have been employed as ancillary ligands (Figure 3-3) in place of the TPA 
Scheme 3-1. A plausible reaction scheme to obtain target species, a pterin-OO-metal complex. 
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ligand to provide a coordination site for accepting the peroxo ligand, as depicted in Scheme 3-1. The 
pyridine rings of the two ligands have π-acceptability to stabilize the reduced species of the pterin complexes. 
Additionally, a rhodium(III) ion was also employed as a metal center with an anticipation for stabilization of 
1e–-reduced pterin by virtue of its higher charge (+3) than that of ruthenium(II). 
[RuIIICl3(TPMOM)]11 and [RuIIICl3(MeBPA)]12 were synthesized based on reported procedures, as 
precursors to synthesize RuII-pterin complexes. To obtain precursors for RhIII-pterin complexes, 
[RhIIICl3(TPMOM)] and [RhIIICl3(MeBPA)], RhIIICl3·nH2O and TPMOM or MeBPA were heated in EtOH at 
reflux; as a result, the crude target complex was obtained in a high yield. The impurities included in the 
crude products of [RhIIICl3(TPMOM)] and [RhIIICl3(MeBPA)] were mainly a rhodium salt and the 
bis-chelate complex, and thus, recrystallization of the crude product from its DMSO solution with addition 
of 2-propanol as a poor solvent gave pure target rhodium(III) complexes, and the purities of the complexes 
were confirmed by their elemental analyses and 1H NMR measurements. 
Pterin complexes, [RuIICl(TPMOM)(Hdmdmp)]+ (6-H+), [RuIICl(MeBPA)(Hdmdmp)]+ (7-H+), 
[RhIII(dmdmp)Cl(TPMOM)]+ (8), [RhIII(dmdmp)Cl(MeBPA)]+ (9) (Figure 3-3), were synthesized in a 
procedure as follows; one of the precursor metal complexes, [MCl3(L)] (M = RuIII or RhIII, L = TPMOM or 
MeBPA), and Hdmdmp were heated in aqueous EtOH (water : EtOH = 1 : 4 v/v) at reflux overnight. The 
RuII complexes, 6 and 7, were obtained as their protonated forms, whereas the RhIII complexes, 8 and 9, were 
isolated as the neutral forms. 
 
3–3 Characterization of Ruthenium(II)- and Rhodium(III)-Pterin-Polypyridyl Complexes 
3–3–1 Spectroscopic Analysis on Protonation-Deprotonation Behavior of Pterin Complexes 
 
Figure 3-3. Structures of ruthenium(II)- and rhodium(III)-pterin complexes as their non-protonated forms. 
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RuII-complex 6-H+ mainly shows two absorption bands in the UV-Vis region in MeCN and the absorption 
maxima were observed at 359 and 547 nm (Figure 3-4A, green line). The absorption band at 359 nm is 
attributed to the MLCT transition from the RuII center to the pyridine rings, on the basis of past reports on 
RuII-TPA complexes: λMLCT for [RuIICl(TPA)]22+ = 355 nm,13 λMLCT for [RuII(dmp)(TPA)]+ = 383 nm (Hdmp 
= 6,7-dimethylpterin).10 Addition of 1 equiv Et3N as a base into a 6-H+ solution in MeCN caused decrease of 
the absorbance both at 359 and 547 nm, and increase of those at 390 and 489 nm, indicating the formation of 
6 by deprotonation (Figure 3-4A). The longer absorption bands of 6-H+ and 6, observed at 547 and 489 nm, 
respectively, can be assigned to the MLCT transition from the RuII center to the pterin ligand, because 
deprotonation of the pterin ligand raises the energy level of the π∗ orbital lying on the pterin ligand, and 
increases the energy required for the MLCT transition. Similar spectral changes derived from deprotonation, 
where the shorter MLCT band was red-shifted and the longer MLCT band was blue-shifted, were also 
observed upon deprotonation of [Ru(Hdmp)(TPA)]2+ in its MeCN solution.10 
The absorption spectrum of 6-H+ was recovered with addition of 1 equiv of TfOH (= 
trifluoromethanesulfonic acid) as a strong acid into the solution of 6 in MeCN, which indicates reversibility 
of the protonation-deprotonation process of 6. With excessive addition of TfOH, further spectral change was 
observed; decrease in the absorption bands of 6-H+ and increase of the absorbance at 660 nm (Figure 3-4B). 
The large red-shift of the MLCT band from 547 to 660 nm indicates the formation of 6-2H+, because the 
large shift is consistent with lowering the energy level of the π∗ orbital lying on the neutral pterin ligand in 
6-H+ due to its further protonation. The reversibility of the protonation-deprotonation behavior between 6-H+ 
and 6-2H+ was also confirmed with addition of Et3N as a base; however, complex 6-2H+ is relatively 
unstable in comparison with 6-H+. Keeping an MeCN solution of 6-2H+ at room temperature overnight gave 
a colorless solution, indicating decomposition of the ruthenium(II)-pterin complex. This instability may arise 
from the fact that the TPMOM ligand binds to the RuII center using three π-accepting pyridine moieties to 
reduce the π-back boding from the RuII center to the protonated pterin ligand, rather than the fact that the 
monocationic H2dmdmp+ ligand should cause electrostatic repulsion against binding to the monocationic 
 
Figure 3-4. Absorption spectral changes in the course of base and acid titration of ruthenium(II)- and rhodium(III)- complexes in 
MeCN at 296 K: (A) deprotonation of 6-H+ upon addition of Et3N, (B) protonation of 6-H+ upon addition of TfOH, (C) 
deprotonation of 7-H+ upon addition of Me3Py, (D) protonation of 7-H+ (17.4 µM) upon addition of TfOH, (E) protonation of 8 
upon addition of TfOH, and (F) protonation of 9 upon addition of TfOH. 
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[RuII(Cl)(TPMOM)]+ unit. The pKa value of 6-H+ in MeCN was determined by UV-vis titration, in which an 
MeCN solution of 6-H+ was titrated by using 2,4,6-trimethylpyridine (Me3Py, pKa of Me3Py-H+ = 14.98)14 as 
a weaker base than Et3N (pKa of Et3NH+ = 18.6)15. The pKa value of the first protonation step to form 6-H+ 
was determined to be 15.4 by fitting analysis of the absorbance change at 560 nm (Figure 3-5A). The pKa 
values of 6-2H+ was also determined to be 1.8 base on fitting analysis of the absorbance change at 660 nm in 
the course the of addition of TfOH (pKa = 2.60)16 (Figure 3-4B, 3-5B). 
In MeCN, RuII-complexes 7, 7-H+, and 7-2H+ show similar protonation-deprotonation behaviors to those 
of 6 and its protonated derivatives upon addition of acids and bases. Since the basicity of 7 and 7-H+ in 
MeCN are important for discussion on the PCET reaction with 1e–-oxidized 7 (See Chapter 4), those were 
determined by titration experiments with acid or base. The pKa value of 7-H+ in MeCN was also determined 
by UV-vis titration to an MeCN solution of 7-H+, prepared by addition of 1 eq of TfOH into a solution of 7, 
 
Figure 3-5. Absorbance changes at selected wavelengths in the course of acid-base titration of ruthenium- or rhodium-pterin 
complexes in MeCN at 296 K and the curve fittings: (A) the deprotonation behavior of 6-H+ upon addition of Me3Py (560 nm), 
(B) the protonation step of 6-H+ upon addition of TfOH (660 nm), (C) the deprotonation behavior of 7-H+ upon addition of Me3Py 
(530 nm), (D) the protonation step of 7-H+ upon addition of TfOH (red: 661 nm, black: 445 nm, green: 549 nm), (E) the 
protonation step of 8 upon addition of TfOH (420 nm) and (F) the protonation step of 9 upon addition of TfOH (411 nm).  
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with Me3Py as a base (Figure 3-4C). In the course of the base titration, the absorption spectrum of 7-H+ 
changed into that of 7; that is, increase in the absorbance at 392 and 495 nm and decrease in those at 326, 
363, and 549 nm were observed with two isosbestic points at 373 and 519 nm, as shown in Figure 3-4C. 
Additionally, the spectrum of 7 turned back to that of 7-H+ again with addition of TfOH as an acid. The pKa 
value of the first protonation step to form 7-H+ was determined to be 16.4 by fitting analysis of the 
absorbance change at 530 nm (Figure 3-5C). The UV-vis titration for further protonation of 7-H+ was 
performed with use of TfOH (pKa = 2.60)16 as one of the strongest acids in MeCN. The second protonation 
showed another spectral change with increase in the absorbance at 300, 446 and 663 nm and simultaneous 
decrease in the absorbance at 326, 363 and 549 nm, implying further protonation of 7-H+ (Figure 3-4D). 
Four isosbestic points were observed at 311, 412, 473 and 588 nm during the second protonation process and 
reversibility of the change was also confirmed by addition of Et3N. The pKa value of the second protonation 
step of 7 to form the diprotonated form, 7-2H+, was determined to be 3.9, by fitting analysis of the 
absorbance change at 594 nm (Figure 3-5D). One of the differences between 6 and 7 is the fact that the 
diprotonated form of 7 (7-2H+) is stable as compared to 6-2H+. Decomposition of 7-2H+ was not observed in 
its MeCN solution even after keeping it for a month. This stability can be attributed to the higher electron 
density at the ruthenium(II) center in 7 (vide infra) than that in 6. The higher electron density at the 
ruthenium(II) center in 7 than that of 6 due to the strongly σ-donating tertiary amino group of the MeBPA 
ligand can compensate the weakened σ-donation from the diprotonated dmdmp ligand, through the π-back 
donation from the ruthenium(II) center to the H2dmdmp+ ligand, which should be strengthened by the higher 
electron density at the ruthenium(II) center. As a result, coordination bonds between the ruthenium(II) center 
and H2dmdmp cation are more stabilized in 7-2H+ relative to those in 6-2H+. The difference among the 
acidities of the ruthenium-pterin complexes also can be attributed to the difference of the electron density at 
the metal center due to that in the coordination environments, three π-accepting pyridines in 6 and two 
π-accepting pyridines and one σ-donating tertiary amino group in 7. The pKa values of 
ruthenium-MeBPA-pterin complexes (7-2H+, 3.9; 7-H+, 16.4) are higher than its corresponding 
ruthenium-TPMOM-pterin complexes (6-2H+, 1.8; 6-H+, 15.4): The lower electron density at metal center in 
protonated species of 6 than those of 7 should cause lowering the electron density on the pterin ligand, and 
the pterin ligand having lower electron density in 6 shows higher acidity than that in 7. 
Protonation behaviors of rhodium(III)-pterin complexes differ from those of ruthenium(II) complexes. 
RhIII-complex 8 shows an absorption band at 421 nm in MeCN, and addition of 1 equiv of TfOH hardly 
causes spectral changes. Upon addition of excess amount of TfOH, decease in absorbance at 421 nm was 
observed, and new absorption bands appeared at 330 and 361 nm (Figure 3-4E). This spectral change 
exhibited two isosbestic points at 392 and 306 nm and continued until addition of 4 equiv of TfOH. Thus, in 
comparison with the cases of 6 and 7, protonation of 8 is hard to proceed; The pKa value of 8-H+ was 
determined to be 2.8, much lower value than those of 6-H+ and 7-H+, based on fitting analysis of the 
absorbance change at 420 nm in the course of the addition of TfOH into 8 solution in MeCN (Figure 3-5E). 
As a further difference from the ruthenium(II) complexes, complex 8-H+ cannot be protonated to obtain the 
diprotonated complex even in the presence of a large excess amount of TfOH, which is regarded as one of 
the strongest acid in MeCN (pKa = 2.60).16 Complex 9 shows similar protonation behaviors to those observed 
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for 8 in MeCN; addition of an excess amount of TfOH into a solution of 9 in MeCN causes decrease in 
absorbance at 411 nm and increase in that at 359 nm, accompanying with two isosbestic points at 307 and 
390 nm (Figure 3-4F), and complex 9-2H+ also cannot be formed even in the presence of a large excess 
amount of TfOH. The pKa value of 9-H+ was also determined to be 3.4 by fitting analysis of the absorbance 
change at 411 nm in the course of the addition of TfOH (Figure 3-5F). In the same way as ruthenium-pterin 
complexes (6 and 7), the protonated MeBPA complexes, 9-H+, shows higher pKa value than that of the 
protonated TPMOM complex, 8-H+, indicating that the rhodium center with MeBPA ligand has higher 
electron density than that of the rhodium center with TPMOM ligand. The differences in the protonation 
behaviors among ruthenium(II)- and rhodium(III)-pterin complexes can be attributed to the difference in the 
valence numbers of the metal centers. The rhodium(III) complexes 8 and 9, which cannot be diprotonated, 
have a larger valence number at the metal center than that of 6 and 7, which should interrupt protonation of 
the RhIII-bound dmdmp– ligand by decrease in the pKa value of the pterin ligand. One of other differences 
between ruthenium(II)- and rhodium(III)-pterin complexes is found in their total charges; complexes 6 and 7 
have no charge, whereas complexes 8 and 9 have +1 charge. However, this difference should not be a cause 
of the difference in their protonation behaviors among the complexes, because [Ru(dmp)(TPA)]+ 10 and 
[Ru(dmdmp)(TPA)]+ (10)10 can be diprotonated by TfOH in MeCN in spite of their +1 total charges. 
3–3–2 1H NMR Spectra of the Pterin Complexes 
In the 1H NMR measurements of the pterin complexes except 7 and its protonated complexes, the pterin 
Figure 3-6. 1H NMR spectra of (A) 6-H+, (B) 7 with K2CO3, (C) 7-H+ with MgSO4, and (D) 7-2H+ with excess amount of TfOH, 
in CD3CN and those of (E) 8 and (F) 9 in CD3OD. The spectrum of 7-2H+ shows a large and broadened signal around 7.8 ppm, 
derived from the large amount of the acid added to the solution. 
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complexes showed distinctive signals in the diamagnetic region, which indicated that the metal centers of 
these complexes were in the d6 low-spin state of RuII or RhIII complexes (Figure 3-6). Except those of 7-H+, 
the 1H NMR signals were assigned by 1H-1H COSY measurements. 
In the 1H NMR spectrum of 6-H+, a singlet signal was observed at δ 4.15 ppm in the typical range of 
chemical shifts for methoxy groups, and four doublet and eight triplet signals were observed in the aromatic 
region (Figure 3-6A). The latter twelve signals were assigned to the signals of three non-equivalent pyridine 
rings of TPMOM, and this assignment was supported by 1H-1H COSY measurements, and thus, formation of 
the TPMOM complexes was confirmed. Since signals of four methyl groups of dmdmp were observed in the 
aliphatic region with expected integration ratios, coordination of the Hdmdmp ligand was also verified. 
Additionally, the hydrogen atom at the 6-position of one of the pyridine rings in 6-H+, which occupied the 
trans-position to the chloride ligand, was shielded by the dmdmp ligand (Figure 3-3), and the 1H NMR 
signal was highly upfield shifted (δ 7.87 ppm) relative to those of the other two 6-position protons (δ 9.28 
and 9.40 ppm), supporting formation of the target structure of 6-H+. 
Diprotonated complex, 7-2H+, also showed distinctive signal in the 1H NMR measurement, which was 
measured by addition of excess amount of TfOH (Figure 3-6D), whereas the 1H NMR signals of 7 and 7-H+ 
were heavily broadened because of a proton exchange at the diprotonated pterin ligand in the presence of 
moisture from the atmosphere. To solve the broadening problem, anhydrous basic K2CO3 as a desiccant was 
added to the CD3CN solution of 7 for elimination of water or other protic species (Figure 3-6B). Addition of 
anhydrous neutral MgSO4 to the solution of 7-H+ was also performed for the 1H NMR measurements to give 
much sharper signals in comparison of those without addition of MgSO4; however, complete sharpness of 
the signals was not achieved for 7-H+ (Figure 3-6C). The 1H NMR signals of pyridine protons in 7 showed 
downfield shifts by protonation, because the reduction of the electron donation from the pterin ligand by 
protonation should cause reduction of the electron density at the ruthenium(II) center; the reduction of the 
electron density at the metal center induces enhancement of donation of the electron density from the 
MeBPA ligand to cause its deshielding (Figure 3-6). The lowest two signals, however, were upfield-shifted 
with protonation (7: 9.46 and 9.56, 7-H+: 9.37 and 9.53, and 7-2H+: 9.07 and 9.41 ppm). The signals can be 
assigned to the hydrogen atoms at the 6-position of the pyridine rings in the MeBPA ligand, and the upfield 
shifts by protonation can be explained by the existence of hydrogen bonding between the chloride ligand and 
the hydrogen atoms at the 6-position of the pyridine rings. The 1H NMR signals of the hydrogen atoms at the 
6-position of the pyridine ring in 7 and its protonated forms showed downfield shifts relative to those at the 
corresponding positions in other complexes, due to the hydrogen bonding. The protonation at the pterin 
ligands should induce reduction of the electron density at the RuII center, and the RuII center should attract 
the chloride ligand more closely to compensate the reduction of the electron density, as reflected on the 
Scheme 3-2. Effect of protonation on the chemical shifts of the 6-H protons of the MeBPA ligand in 7 
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change of the Ru-Cl bond lengths in the crystal structures (Ru-Cl for 7: 2.437(2) Å, Ru-Cl for 7-H+: 
2.4220(8) Å, vide infra). The relatively electron-poor chloride ligands are expected to form weaker hydrogen 
bonds with the hydrogen atoms at the 6-positions, which probably cause the upfield shifts of the 1H NMR 
signals upon protonation of 7 (Scheme 3-2). 
In the 1H NMR spectrum of 8 in CD3OD, similar features to those of 6-H+ were observed (Figure 3-6E). 
Three methyl signals of the dmdmp ligand and twelve aromatic signals of the pyridine rings were observed, 
and the 1H NMR signal of the hydrogen atom at the 6-position for one of the pyridine rings, which probably 
occupied the trans-position to the chloride ligand, was largely upfield shifted (δ 8.11 ppm), relative to those 
of the other two 6-position protons (δ 9.34 and 9.37 ppm). This upfield shift is probably derived from the 
overlapping of the proton on the ring current of the dmdmp ligand as observed for 6-H+ (See below). 
Additionally, almost of all 1H signals for 8 exhibited downfield shifts in comparison to those of 6-H+, which 
derived from increase in the valence number of the metal center from +2 (RuII) in 6 to +3 (RhIII) in 8. 
The lowest two 1H NMR signals of 9 observed at δ 9.37 and 9.45 ppm are much downfield shifted 
relative to those of RhIII-polypyridyl complexes; for example, [RhIII(bpy)3]3+ (bpy = 2,2’-bipyridyl) showed 
the 1H NMR signals at δ  9.04 ppm for the protons at the 6-position of the pyridine rings in CD3OD.17 The 
downfield shifts for the signals of 9 indicate that the 6-position protons of 9 also form hydrogen bonding 
with the chloride ligand, similarly to those of 7-H+. From this viewpoint, the author assumed that complex 9 
has the same coordinating structure as that of 7-H+. 
 
3–3–3 ESI-TOF-MS Spectra of Pterin Complexes 
Formation of 6-H+, 7-H+, 8, and 9 were also confirmed by ESI-TOF-MS spectrometry as shown in Figure 
3-7. Complexes 6 and 7 are neutral complexes, and thus, these species cannot be directly detected by the 
mass spectrometry. Complex 6-H+ in its acetone solution mainly showed a peak cluster at m/z = 633.2, 
exhibiting the distribution pattern corresponding to a species having one ruthenium and one chlorine ions 
(Figure 3-7A). This signal could be assigned to 6-H+ (calcd. for [RuIICl(TPMOM)(Hdmdmp)]+: m/z = 633.1). 
A weak peak cluster assignable to [6-Na]+ (calcd. for {[RuII(dmdmp)Cl(TPMOM)]0 + Na}+: m/z = 655.1) 
was also observed at m/z = 655.1 The formation of 7-H+ was also supported by the ESI-TOF-MS spectrum of 
7-H+ in acetone, which showed peak clusters at m/z = 569.1 (calcd. for [7 + H]+ 
([RuIICl(MeBPA)(Hdmdmp)]+): m/z = 569.1) and at m/z = 591.1 (calcd. for [7 + Na]+ ({[RuII(dmdmp)Cl- 
(MeBPA)]0 + Na}+): m/z = 591.1) (Figure 3-7B). 
In contrast to the ruthenium(II)-pterin complexes 6-H+ and 7-H+, the mass signals of Rh-complexes do 
not have characteristic distribution patterns, because Rh atom is composed of one stable isotope (103Rh = 
100.00%). The ESI-TOF-MS spectrum of 8 in MeOH showed only one peak cluster at m/z = 633.2, and the 
distribution pattern of the peak cluster indicated that the ion had one chlorine atom (Figure 3-7C). Thus, the 
signal can be assigned to [8]+ (calcd. for [RhIII(dmdmp)Cl(TPMOM)]+: m/z = 633.1). The ESI-TOF-MS 
spectrum of 9 in MeOH also showed a peak cluster at m/z = 569.1, assignable to the signal of [9]+ (cacld. for 
[RhIII(dmdmp)Cl(MeBPA)]+: m/z = 569.1) (Figure 3-7D). 
 
3–3–4 Crystal Structures of 7 and 7-H+ 
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Single crystals of 7 and (7-H+)·PF6 suitable for X-ray crystallography were obtained by slow 
concentration of their solutions in CD3CN and (CD3)2CO, respectively, through vaporization of the solvents. 
Crystal structures of 7 and 7-H+ are shown in Figure 3-8 with the atom labeling. The geometries around the 
RuII ions of 7 and 7-H+ are octahedral with slight distortion as a typical coordination structure of a RuII 
complex bearing 5-membered chelate rings. The bond lengths around the Ru centers fall in the typical range 
of those of RuII complexes.18 As described above, the pterin ligand of 7 can accept a proton relatively easily 
at one of the nitrogen atoms, and hence the crystal structures of 7 and 7-H+ were distinguished based on the 
number of counter anions included in the crystal structure. The crystal of 7 contained no counter ion, 
whereas the crystal of 7-H+ did one PF6– per one Ru-pterin-MeBPA moiety. The deprotonated dmdmp– 
ligand has two possible resonance forms as shown in Scheme 3-3, amidate and imidate forms. The pterin 
ligand of 7 can be considered as in between the imidate form and the amidate one. The bond length of 
C2-O1 (1.273(6) Å) is longer than those of carbonyl C=O bonds (1.20 – 1.23 Å)19 and shorter than those of a 
phenolic C-O single bond (ca. 1.36 Å)19 and the bond length of C2-N2 (1.343(9) Å) is shorter than those of 
C-N single bonds found in the MeBPA ligand (1.49 – 1.52 Å) and rather close to those found in the pyridine 
 
Figure 3-7. ESI-TOF-MS spectra of 6-H+ (A) and 7-H+ (B) in acetone and those of 8 (C) and 9 (D) in MeOH. Observed spectra: 
black traces, and their simulations: red traces. 
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rings of MeBPA (1.34 – 1.36 Å). On the other hand, in the crystal structure of 7-H+, the N1 atom of a 
molecule and Cl1 atom of another molecule are close to each other, which indicates that there is hydrogen 
bonding between them (N1···Cl1: 3.285(2)Å) (Figure 3-9). Thus, the pterin ligand of 7-H+ in the crystal is 
protonated at the N1 atom (formally at the 1-position in the pteridine skeleton). The pterin ligand of 7-H+ 
was also recognized to be in between the imidate form and the amidate one as observed in 7, on the basis of 
the bond lengths of C2-O1 (1.261(4) Å) and C2-N2 (1.340(3) Å). Thus, regardless of the protonation of N1 
nitrogen, the pterin ligands in 7 and 7-H+ are in the anion-delocalized form as shown in Scheme 3-3. 
As a difference between the crystal structures of 7 and 7-H+, the bond length of Ru-N3 was slightly 
elongated with protonation (Ru-N3 for 7: 2.064(4) Å, Ru-N3 for 7-H+: 2.078(2) Å). This elongation should 
be derived from reduction of electron-donating ability of the pterin ligand due to its protonation, which 
 
Figure 3-9. Hydrogen bonding between the chloride ligand of a cationic moiety and N1-H of another cationic moiety, observed in 
the crystal structure of 7-H+·PF6. Counter ions were omitted for clarity. 
Scheme 3-3. Two resonance forms and an anion-delocalized form of RuII-dmdmp complexes 
 
 
Figure 3-8. ORTEP drawings of (A) 7, (B) 7-H+·PF6 and (C) 8·Cl with thermal ellipsoids at the 50% probability level. The 
hydrogen atoms in (A) – (C) and the counter ions in (B) and (C) are omitted for clarity. A hydrogen-bonded water molecule is 
shown in (C). Pyridine rings of 7 are labeled as "A" and "B" to clarify assignments of 1H NMR signals in the experimental section. 
Ru-Cl for 7: 2.437(2) Å, Ru-Cl for 7-H+: 2.4220(8) Å, Rh-Cl for 8: 2.332(1) Å. 
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causes the charge neutralization of the pterin ligand. In contrast, the bond length of Ru-Cl was shortened 
upon protonation (Ru-Cl for 7: 2.437(2) Å, Ru-Cl for 7-H+: 2.4220(8) Å), because the electron donation 
from the pterin ligand to the RuII center was reduced due to the protonation. To compensate the reduced 
electron density, the RuII center attracts the chloride ligand more strongly. In both crystal structures of 7 and 
7-H+, steric repulsion was recognized between the pyridine ring containing N7 atom in the MeBPA ligand 
and the methyl group at the 6-position of the pterin ligand. As a result of the steric repulsion, the bond angles 
of N3-Ru-N7 became larger than 90° (∠N3-Ru-N7 for 7: 106.3(2)°, ∠N3-Ru-N7 for 7-H+: 103.81(9)°). 
Although the two donating ligands, the π-donating chloride and σ-donating tertiary-amine ligands, bind at 
the trans positions to each other in 7 and 7-H+, the structures should be stabilized by intramolecular 
hydrogen bonding among the chloride ligand and the hydrogen atoms at the 6-positions of the pyridine rings 
of MeBPA. In the crystals of 7 and 7-H+, the distances between the chloride ligand and the carbon atoms at 
the 6-positions of the two pyridine rings in the MeBPA ligand are 3.372(6) Å and 3.345(7) Å for 7, and 
3.337(4) Å and 3.353(3) Å for 7-H+, respectively. The distances are in the normal range (3.3 – 3.7 Å) of the 
distances between chloride and carbon atoms having non-classical hydrogen bonding.20 The 1H NMR spectra 
of 7 and 7-H+ in CD3CN also exhibited downfield shifts due to the hydrogen bonding (see above). 
Additionally, in the crystal structure of [RuIIICl3(EtBPA)],12 which resembles to the synthetic starting 
material of 7, similar hydrogen bonding was observed between one of the chloride ligands, located at the 
trans position of the tertiary-amine nitrogen atom of the EtBPA ligand, and the C-H bond at the 6-position of 
the pyridine rings of the EtBPA ligand, judging from the C···Cl distances: 3.224(4) and 3.263(5) Å.12 The 
hydrogen bonding in the RuIII complex of the starting material probably makes the chloride ligand trans to 
the tertiary-amino nitrogen more inert against ligand-substitution reaction than the other two chloride ligands. 
Furthermore, the hydrogen bonding in 7 can cause its higher thermal stability compared to other possible 
isomers, having different coordination arrangements. 
 
3–3–5 Crystal Structure of 8 
A single crystal suitable of 8·Cl for X-ray crystallography was obtained by slow concentration of its 
CH2Cl2 solution through vaporization of the solvent. A crystal structure of the cationic part of 8·Cl with the 
atom labeling is shown in Figure 3-8C, which contains a hydrogen-bonded water molecule. The geometry 
around the RhIII ion of 8 is octahedral with slight distortion as a typical coordination structure of a RhIII 
complex bearing 5-membered chelate rings and the bond lengths around the metal center fall in the typical 
range of those of RhIII complexes. As proposed in the 1H NMR measurements of 8 (Chapter 3-3-2), a 
hydrogen atom at 6-position of the pyridine ring locating at the trans position to the chloride ligand is 
shielded by the dmdmp ligand, as can be seen in the crystal structure (Figure 3-8C). The N3 atom of 8 and 
the O3 atom of a co-crystallized water molecule form a hydrogen bond, judging from the short distance 
between N3 and O3 atoms (N3···O3: 3.018(9)Å) (Figure 3-8C). 
The bond length of C1-O1 (1.293(4) Å) is close to the bond length of the corresponding C-O bonds in the 
crystal structures of 7 (1.273(6) Å) and 7-H+ (1.261(4) Å), and shorter than those of a phenolic C-O single 
bond (ca. 1.36 Å).19 Judging from the C-O and C2-N1 bond lengths (1.362(5) Å), the dmdmp ligand in 8 is 
also in between the imidate form and the amidate one, i. e., an anion-delocalized form as observed in 
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RuII-pterin complexes.10 The bond length between the chloride ligand and the RhIII center is shorter than 
those of the RuII-complexes, 7 (2.437(2) Å) and 7-H+ (2.4220(8)) Å), which is reasonable due to the smaller 
ionic radius of RhIII than that of RuII. Comparison of bond lengths between its metal center and dmdmp 
ligand of 8 with those of 7 or with those of 7-H+ may contribute to exploration to the influence of the 
electron density at the metal center on the electronic structure of the pterin ligand; however, the coordination 
structures of the dmdmp ligands in 7 and 7-H+ are distorted by steric repulsion between one of the pyridine 
rings of MeBPA and one of the methyl groups of the dmdmp ligand (See above). Therefore, detailed 
discussion on the difference among these bonds lengths is not made in this study. 
 
3–3–6 Electrochemical Measurements of the Pterin Complexes 
As mentioned above, formation of 1e–-reduced species of the pterin complexes is necessary to obtain the 
target species, pterin-OO-metal complexes. Thus, electrochemical measurements of the pterin complexes 
were performed to reveal their reduction behaviors in MeCN containing 0.1 M TBAPF6 as an electrolyte at 
 
Figure 3-10. CVs and DPVs of the pterin-complexes. (A) 6 (red), 6-H+ (black), and 6-2H+ (blue). (B) 7 (red), 7-H+ (black), and 
7-2H+ (blue). (C) 8 (black), and 8-H+ (blue); (D) 9 (black), and 9-H+. (blue). 
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room temperature. 
At first, the oxidation behaviors of the RuII-pterin complexes were investigated (Figure 3-10 and Table 
3-1). All of the ruthenium(II)-pterin complexes show a reversible wave, assigned to reversible 1e– oxidation 
process at the ruthenium center for the RuII/RuIII redox couple, regardless of its protonated states at the pterin 
ligand. In comparison of the first oxidation potentials (EOX) among 6, 7, and their protonated complexes, and 
ruthenium-TPA-dmdmp complexes (10 and its protonated forms), insights into the electronic interaction 
between the metal center and the pterin ligand were gained as mentioned below. The first protonation of the 
pterin ligand causes a large positive shift of EOX(RuII/RuIII), which indicates that the protonation of the pterin 
moiety reduces the electron density of the ruthenium center. The second protonation also raises the potential, 
but the degrees of the rise on the potentials are not so large as compared to that by the first protonation (ΔE 
by the first protonation, ~0.3 V; ΔE by the second protonation, < 0.1 V). The difference in the impact on 
EOX(RuII/RuIII) between the first and second protonation steps indicates that the first protonation more 
significantly reduces the electron density at the ruthenium center than the second protonation. In the UV-Vis 
spectra of 6, 7, 10 and their protonated forms, both of the first and second protonation caused red-shifts of 
the absorption bands due to MLCT transitions from the RuII center to the pterin ligand in similar degrees 
(See Chapter 3-3-1). Therefore, both of the first and second protonation lower the energy levels of 
π*-orbitals of the Hdmdmp and H2dmdmp+ ligands, respectively, as compared to that of the dmdmp– ligand; 
however, in the case of the second protonation, the compensation of the electron density at the metal center 
by other ligands is probably strong, and thus, the EOX(RuII/RuIII) values are not so altered between the 
mono-protonated and diprotonated complexes. 
Comparing the the EOX(RuII/RuIII) values of 6, 7 and 10 with those of the corresponding species 
protonated at the dmdmp ligand, the values can be arranged in the order as follows; 10 > 6 > 7. The order of 
EOX(RuII/RuIII) is reasonable in the light of the coordination structures of the ruthenium-pterin complexes. 
Besides dmdmp–, all of the three ruthenium-complexes have pyridine rings, a tertiary amine, and/or a 
chloride ion as ligands. Pyridine rings are a neutral ligand and known for its strong π-acceptability from the 
ruthenium(II) center, and a chloride ion is regarded as a strong π-donating ligand with the –1 charge. Based 
on the characteristics, the coordination of a tertiary amine increases the electron density at the ruthenium 
Table 3-1. Redox Potentials (V vs SCE) of the RuII- or RhIII-Pterin Complexes in MeCN 
Complex EOX(RuII/RuIII) ERED(dmdmps) ERED(RhIII/RhI) 
6 +0.44 not observed — 
6-H+ +0.71 –1.66* — 
6-2H+ +0.76 –0.22 — 
7 +0.24 not observed — 
7-H+ +0.54 –1.80* — 
7-2H+ +0.62 –0.28* — 
8 — –1.67 –0.81* 
8-H+ — –0.45* –1.05* 
9 — not observed –0.89* 
9-H+ — –1.05* –0.39* 
10 a +0.66 –1.68 — 
10-H+ a +0.92 –0.99* — 
10-2H+ a +0.94 –0.26 — 
*: irreversible redox processes, whose potentials were determined with the DPV peaks. a ref. 10. 
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center, in comparison with that of a pyridine ring, and the chloride ion much more increases the electron 
density at the ruthenium center with use of its π-donating character and negative charge. Hence, the electron 
density at the ruthenium center in 7 is higher relative to that in 6, because complex 7 has a tertiary amino 
nitrogen coordinating to the RuII center instead of a pyridine ring in comparison to the structure of 6. On the 
other hand, the electron density at the ruthenium center in 6 is higher relative to that in 10, because complex 
6 has a chloride ligand coordinating to the RuII center instead of a tertiary amino nitrogen in comparison to 
the structure of 10. In consequence, the order of EOX(RuII/RuIII) among 6, 7 and 10 is recognized as 
mentioned above. In the electrochemical measurements of the rhodium-pterin complexes, no oxidation 
waves were observed except for that of oxidation of the Cl– ion serving as a counter ion for 8 and 9. 
To obtain the target compound, a pterin-OO-metal species, a reversible reduction process of the pterin 
ligand is indispensable, because the target species can be obtained with the reaction of the 1e–-reduced pterin 
species with a O2•– ion (Scheme 3-1). In the previous report,10 the first reduction processes of the pterin 
ligands in 10 and its diprotonated forms were revealed to be reversible, whereas 1e–-reduction of the 
monoprotonated complex of 10 was irreversible due to a proton-shift from the N1 position to the N8 position 
in the pterin framework, induced by the reduction.21 However, except 6-2H+, all of the pterin complexes 
synthesized in this research, having one of the tridentate ligands, did not show reversible reduction behaviors. 
Non-protonated RuII complexes, 6 and 7, and the monoprotonated complexes, 6-H+ and 7-H+, showed 
irreversible reduction waves in their electrochemical measurements (Figure 3-10). One of the most important 
differences found among 6, 7, and 10 is the electron density at the ruthenium(II) center, as exemplified by 
the EOX(RuII/RuIII) values; 6: +0.44 V, 7: +0.24 V, 10: +0.66 V vs SCE. This difference probably gives 
impacts on the stability of the reduced pterin species; as mentioned in Chapter 1-5, the positive charge of the 
metal center stabilizes the reduced form of the pterin ligands. Therefore, due to their higher electron densities 
at the ruthenium(II) centers in 6 and 7 than that in 10, the ruthenium(II) centers of 6 and 7 cannot sufficiently 
cancel out the negative charge of 1e–-reduced pterin species and cannot stabilize them. 
The diprotonated complex 7-2H+ also did not show any reversible reduction processes on the pterin 
ligand, whereas complex 6-2H+ showed a reversible reduction process at –0.22 V in the CV measurement as 
shown in Figure 3-10A (blue trace). This difference in the reversibility of the reduction process between 
6-2H+ and 7-2H+ can be also attributed to the difference in the electron density at the ruthenium center 
between 6-2H+ and 7-2H+; the EOX(RuII/RuIII) values of 6-2H+ (+0.76 V vs SCE) and 7-2H+ (+0.62) indicate 
that the electron density at the ruthenium center in 6-2H+ is lower than that in 7-2H+. As mentioned in 
Chapter 1-5 and in discussion about the irreversibility in the reduction processes of 6 and 7 (see above), the 
positive charge at the metal center is expected to cancel the negative charge of the reduced ligand and 
resultantly stabilize the ligand-reduced species. Therefore, the electron density at the ruthenium center in 
6-2H+ is assumed to be low enough to stabilize the reduced pterin species in the coordination sphere, while 
that in 7-2H+ is too high to stabilize the reduced pterin species.22 
On the other hand, in electrochemical measurements of the non-protonated rhodium(III) complexes, 8 and 
9, in MeCN, the rhodium(III) center is firstly reduced and the process is highly irreversible as a typical 
behavior of rhodium(III) complexes.25 The irreversibility of the redox process at the RhIII center prevents 
discussion on the reduction process of the RhIII-pterin complexes in detail. Even after protonation of 9, the 
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first reduction proceeded not on the dmdmp ligand but at the rhodium(III) center (Table 1). For the 
electrochemical measurement of 8-H+, a reduction wave was observed at –0.45 V vs MeCN. A reduction 
process of rhodium(III)/rhodium(I) in rhodium(III)-polypyridyl complexes is known to generally show a 
typical wave shape in the CV;25 however, the reduction wave observed in the electrochemical measurements 
with 8-H+ was different from the typical shape. Additionally, the reduction potential of the process (–0.45 V) 
is higher relative to those reported for reduction processes of rhodium(III) centers; for example, 
[RhIIICl2(bpy)2]+ shows its Ered(RhIII/RhI) value of –0.92 V vs SCE in DMF.26 Therefore, the reduction wave 
of 8-H+ at –0.45 V vs SCE can be assigned to the reduction process of the pterin ligand. However, the first 
reduction wave of 8-H+ is irreversible and thus any RhIII complexes involving the reduced pterin species are 
hard to be obtained from chemical reduction of 8-H+. In consequence, the reversibility in the reduction 
process and the high ERED value indicate that complex 6-2H+ can be reduced with chemical reductants under 
ambient conditions, and thus, complex 6-2H+ can be regarded as the best candidate for the precursor 
complex among the pterin complexes studied here to obtain the target pterin-OO-metal species. 
 
3–4 Attempt at Formation of RuII-(H2dmdmp-O2) Species 
As mentioned above, formation of the target pterin-OO-metal species was attempted as described in the 
Scheme 3-1: 1e– reduction of 6-2H+ and the subsequent reaction with O2•–. In this study, cobaltocene (EOX = 
–0.9 V vs SCE in MeCN)27 was employed as a reductant and KO2 was employed as a O2•– source in the 
presence of 18-crown-6 as a K+ trapping reagent. TfOH was chosen as a proton source to produce 6-2H+, 
because of its almost the highest acidity in MeCN and good stability; in contrast, HClO4 has high acidity 
comparable to that of TfOH but not so stable in aprotic solvents. To the solution of 6-2H+, obtained from 
addition of excess TfOH into a solution of 6-H+ in MeCN, was added cobaltocene, and UV-vis spectral 
change was observed (Figure 3-11). However, the obtained spectrum after addition of cobaltocene was 
reminiscent of that of 6-H+ and production of 6-H+ was also confirmed by ESI-TOF-MS measurements. This 
result suggests that, although the diprotonation of 6 requires presence of an excess amount of a strong acid, 
cobaltocene may reduce proton derived from a strong acid such as TfOH in MeCN, decreasing the proton 
concentration to afford 6-H+. 
To avoid decomposition of a strong acid, the reactions were attempted in propionitrile at 0 °C or at –
 
Figure 3-11. UV-Vis spectral change in the course of addition of cobaltocene into the solution of 6-2H+ in MeCN at room 
temperature in the presence of 6 equiv TfOH, and UV-vis spectrum of 6-H+ in MeCN. 
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85 °C, the latter of which was the lowest temperature limit of the cooling apparatus in propionitrile (m.p.: –
92 °C). However, at low temperature, complex 6-H+ was not diprotonated to form 6-2H+ even in the 
presence of 5 equiv of TfOH, whereas complex 6-H+ was almost completely diprotonated with the same 
amount of TfOH at room temperature. The diprotonation of 6 is not favorable even at room temperature, and 
thus, the equilibrium constant on the protonation reactions of 6-H+ with TfOH probably decreases at low 
temperature to interrupt further protonation of 6-H+. Hence, ~1000 equiv TfOH was added into a solution of 
6 in MeCN to produce 6-2H+ at –85 °C, and then, the formation of 6-2H+ was spectroscopically confirmed 
(Figure 3-12, orange line). The large mount of TfOH, however, caused problems; for example, cobaltocene 
as reductants reacted with TfOH even at low temperature due to increase in the amount of TfOH, and 
resultantly, ~12 equiv cobaltocene was necessary to complete the UV-Vis spectral change (Figure 3-12A). 
To the solution of 6-2H+ after reaction with 12 equiv cobaltocene at –85 °C, KO2 was added, together with 
0.5 equiv of 18-crown-6, to form the target species; however, excess amount of KO2 was required to 
complete the spectral change and in the final spectrum, no absorption bands were observed over 400 nm, 
indicating decomposition of the RuII complexes. Hence, to confirm the reversibility of the reduction process 
of 6-2H+ with 12 equiv cobaltocene at –85 °C, tris(4-bromophenyl)aminium hexachloroantimonate (TBAH) 
was added as a 1e– oxidant into the reaction mixture before addition of KO2. As a result, in the course of 
reoxidation, a new absorption band at ~850 nm was observed (Figure 3-12B), indicating that a non-desired 
side reaction proceeded. The severe reaction conditions including use of a large amount of the strong acid, 
dry and deaerated atomosphre, and operation at low temperature, interrupted additional measurements such 
as ESI-TOF-MS spectrometry, NMR spectrosocopy, and so on. Therefore, the cause of the spectral changes 
with increase in the absorbance around 850 nm has yet to be clarified; note that 1e–-reduced 6-2H+ was 
probably not obtained in the experiment. 
 
3–5 Summary 
To gain insights into the substrate oxidation by pterin-dependent hydroxylases in nature, the author 
attempted to obtain a pterin-OO-metal species, which is assumed to be the most plausible candidate of the 
active species in the oxidation reactions with the pterin-dependent enzymes. For this purpose, novel 
ruthenium(II)- and rhodium(III)-pterin complexes were synthesized and characterized especially with the 
electrochemical methods. The electrochemical and UV-vis measurements of the pterin complexes indicated 
 
Figure 3-12. UV-Vis spectral change in the course of addition of a reductant and an oxidant into the solution of 6-2H+ in 
propionitrile at –85 °C in the presence of 870 eq TfOH; (A) addition of cobaltocene and (B) subsequent addition of TBAH. 
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that selection of the metal center and ligands to prepare the pterin complexes is quite important for 
stabilization of the 1e–-reduced pterin ligand. The diprotonated ruthenium(II)-pterin complex, 6-2H+, was 
regarded as the best candidate for a precursor to the target pterin-OO-species, and thus, attempts to prepare 
the target peroxo complexes were performed by chemical reduction of 6-2H+ and subsequent addition of O2•– 
to solutions containing the reduced 6-2H+. However, the severe reaction conditions such as addition of a 
large amount of a strong acid interrupted formation of the target species. 
In spite of efforts to search for appropriate reaction conditions including temperature, solvent, reductant, 
and acid, chemical reduction of 6-2H+ was not successful. Consequently, reconsideration on the design and 
synthesis of novel pterin complexes should be necessary to obtain the target peroxo species. The problems 
found for the dmdmp– complexes in this work are low protonation efficiency and irreversibility of the 
reduction processes. The irreversibility of the reduction processes for the monoprotonated pterin complexes 
can be derived from the proton-shift behaviors during the reduction process (Figure 3-13A).21 To solve these 
problems, utilization of N-alkyl-pterin complexes,28 which have alkylated N atom(s) instead of protonated N 
atom(s) in the pterin ligand, is one of the alternatives, because the N-alkyl-pterin ligand is equivalent to the 
monoprotonated pterin ligand in terms of the electronic structures, and thus, a high reduction potential of the 
reduction process comparable to that of the monoprotonated complexes can be expected. Moreover, the alkyl 
groups are probably not eliminated nor shifted during the reduction processes, and thus, high reversibility of 
the reduction process can be expected (Figure 3-13B). 
  
 
Figure 3-13. (A) Deprotonation and proton-shift of a protonated dmdmp complex and (B) dealkylation and alkyl-shift behaviors of 
alkylated dmdmp complex. 
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Chapter 4 Oxidation of C–H bonds in Hydrocarbons by Ruthenium(III)-Pterin Complexes 
 
4–1 Introduction 
Proton-coupled electron transfer (PCET) provides an energetically feasible pathway for H-atom 
abstraction from a substrate with an oxidant (See Chapter 1-4).1 In PCET reactions, an oxidant receives one 
electron and one proton from substrates at different sites; i.e., an electron goes to an electron accepting site 
and a proton moves to a proton accepting site.2 The concerted processes reduce the activation free-energy, 
∆G‡, in oxidation of hydrocarbons despite their high oxidation potentials (normally, > 2 V vs SCE).1b 
Because of this advantage, PCET reactions are widely employed not only in biological redox reactions but 
also in production of fine chemicals in chemical industry.3,4 In biological systems, oxidation reactions 
through a PCET process are also conducted at an active center by oxidation enzymes;5 for example, 
lipoxygenase,6 methane monooxygenase,7 ribonucleotide reductase,8 and cytochrome P450s9 oxidize organic 
substrates at the active sites including transition-metal complexes. The active sites of the enzymes are well 
characterized and many research groups have synthesized transition-metal complexes as functional models to 
gain mechanistic insights into the enzymatic oxidation reactions and to learn splendid methods for oxidation 
of organic molecules.5, 10-12 
Hydrogen-atom transfer (HAT) reactions can be categorized into 4 types; (1) transfer of H atom from a 
substrate to a single atom such as an oxyl group in an oxidant, (2) electron transfer followed by proton 
transfer (ET/PT), (3) proton transfer followed by electron transfer (PT/ET), and (4) concerted 
proton-electron transfer (CPET).1b The latter three types are recognized as PCET, in which a proton and an 
electron are transferred from a substrate to two different sites of the oxidant as mentioned above, in terms of 
weak coupling between electron donor and acceptor.13 In CPET reactions, the "oxidation power" of an 
oxidant can be defined by the bond dissociation enthalpy (BDE) of a 1e–/1H+-reduced form of the oxidant.14 
Also, the inertness of a substrate in HAT can be judged from the BDE value of an X-H bond to be cleaved. 
BDE values of the reduced species obtained from oxidants are determined from the pKa value of its 
conjugate acid and the redox potential (E1/2),15 which correspond to the Gibbs free-energy change of the 
PCET reaction. The BDE value can be defined by eq 1:16-19 
 
BDE (kcal mol–1) = 2.303RT(pKa) + F(E1/2) + C   (1) 
 
In eq 1, R, F, Eox and C refer to the gas constant, the Faraday constant, one-electron oxidation potential, 
and a proportionality constant in a certain solvent, respectively. Thus, the high pKa and high Ered values result 
in high BDE of the reduced species obtained from the oxidant to promote the oxidation reaction. The 
correlation between the oxidation reactivity of an oxidant and the BDE value of an oxidant as a hydrogen 
atom acceptor has been well investigated by many researchers mainly with high valent metal-oxo complex as 
an oxidant.20 In high-valent metal-oxo species, the oxo group of the oxidants can behave as good proton 
acceptors driven by its –2 charge, and the metal center should acts as good electron acceptors by virtue of its 
high valency. Therefore, many researchers have used metal-oxo species in CPET reactions. As one of the 
reports investigating reactivity in PCET, Que, Shaik, Nam and coworkers compared reactivity among 
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non-heme iron(IV)-oxo complexes showing close calculated BDE values in C-H abstraction reactions, to 
conclude that the involvement of the quintet state of iron(IV)-oxo complexes should be important in 
enhancing the reactivity of H-atom abstraction.21 As mentioned above, an important factor to determine the 
reactivity of an oxidant in PCET reactions is its BDE value, which can be divided into two components, i.e., 
pKa and E1/2. Determination of the E1/2 value of metal-oxo complexes is relatively easy, and thus, correlation 
between the E1/2 value and the reactivity as an oxidant has been discussed for several metal-oxo complexes; 
for example, Que and coworkers determined the reduction potential of [FeIV(O)(N4Py)]2+ (+0.50 V vs SCE 
in MeCN) by spectropotentiometry,11 and concluded that the higher reactivity of [FeIV(O)(N4Py)]2+ than 
Fe(IV)-oxo-tetramesitylporphyrin (+0.29 V)22 and Fe(IV)-oxo-trisureaylate (–0.06 V)23 was attributed to its 
high potential among the FeIV-oxo complexes.11 On the other hand, the correlation between pKa of oxidants 
and their reactivity in C-H oxidation has never been clarified yet, due to the difficulty in the determination of 
pKa values of metal-oxo species, because metal-oxo complexes are generally unstable and usually not 
capable of accepting a proton in an acid-base reaction. 
Besides the C-H oxidation by metal-oxo complexes mentioned above, no report has described systematic 
investigation on C-H oxidation reactions with metal complexes without oxo ligands.24 Mayer and coworkers 
have reported that PCET oxidation of O-H bonds in substrates such as phenol derivatives and TEMPOH can 
be achieved by using Ru(III) and Fe(III) complexes having basic sites in the ligands without oxo ligands.25,26 
It should be important to develop oxidants without oxo ligands for expansion of versatility in C-H oxidation 
reactions and this strategy may make it possible to construct catalytic oxidation systems without using 
hazardous peroxides or aqua complexes as precursors, which can be used only in aqueous media. 
In order to clarify controlling factors of the reactivity of oxidants in C-H bond cleavage via HAT, the 
author examined metal complexes bearing a basic site as a proton-accepting site, without oxo ligands. As a 
proton-accepting site, a pterin derivative was selected. Pterins are heteroaromatic coenzymes, which play 
crucial roles in biological redox reactions (See Chapter 1-3).27,28 Additionally, transition-metal complexes of 
pterin derivatives have attracted much attention due to their unique redox behaviors (See Chapter 3).29,30 For 
example, our research group has reported that the 1e–-oxidized species of a RuII-pterin complex, 
[RuII(dmdmp)(TPA)]+ (10: Hdmdmp = N,N-dimethyl-6,7-dimethylpterin, TPA = tris(2-pyridylmethyl)amine; 
see Scheme 1),31 was revealed to perform oxidation reactions of phenol derivatives through a PCET 
mechanism.32 However, H-atom abstraction reactions from C-H bonds have never been performed. In this 
chapter, the ruthenium(II)-pterin complex, [RuII(dmdmp)Cl(MeBPA)] (7: MeBPA = N-methyl-N,N-bis(2- 
pyridylmethyl)amine; see Scheme 1), and complex 10 were employed. Complex 7 has a similar structure to 
that of 10, except possession of a chloride ligand, instead of one pyridine ring of the TPA ligand in 10. Note 
that both the complexes do not have oxo ligands in the structures. The alteration of coordination 
environments between the two complexes involves total charges of the cation moieties, the pKa values of the 
pterin ligand and 1e–-oxidation potentials of the metal centers as mentioned in Chapter 3 to regulate the 
reactivity of the complexes in PCET reactions. The author herein compares the reactivity of 1e–-oxidized 7 
and 10 in oxidation of organic substrates, involving H-atom abstraction from C-H bonds of substrates, to 
explore the effect of the differences in the electron-acceptability reflected on the pKa values and the 
proton-acceptability reflected on the redox potentials between 7 and 10 on the substrate oxidation through a 
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PCET mechanism. The purpose of this study is (1) clarification of the fact that non-metal-oxo oxidants 
having proton- and electron-accepting sites are capable of performing sufficient C–H bond oxidation and (2) 
gaining insights into impacts of proton- and electron acceptability of the oxidants on the transition states in 
PCET oxidation reactions of C–H bonds. 
 
4–2 Determination of BDE values 
The pKa values of 7-H+ and 7-2H+ in MeCN were determined by UV-vis titration experiments (16.4 for 
7-H+ and 3.9 for 7-2H+) as described in Chapter 3. The pKa value of 10-H+ was also reexamined in this work 
by using the same method for 7-H+ as mentioned in Chapter 3; the pKa value of 10-H+ was determined to be 
14.3 using Me3Py (pKa of Me3Py-H+ = 14.98)33 as a base. The pKa values of 10-H+ (14.3) and 10-2H+ (2.0)32 
are much smaller than those of 7-H+ and 7-2H+, respectively, indicating higher acidity of 10-H+ and 10-2H+ 
than that of 7-H+ and 7-2H+. Therefore, the dmdmp ligand in 7 has stronger basicity than that in 10, 
reflecting larger electron density of the RuII center caused by ligand alteration from a π-accepting and neutral 
pyridine ligand to a π-donating and anionic chloride ligand. Thus, it has been revealed that proton 
acceptability of 7 is much larger than that of 10 in PCET reactions. 
As mentioned in Chapter 3, all of 7, 7-H+ and 7-2H+ showed one reversible oxidation waves at +0.24, 
+0.54, and +0.62 V vs SCE in MeCN, respectively, which were assigned to the RuII/RuIII processes (Figure 
3-10 in Chapter 3). The large positive shift with the first protonation of the pterin ligand and the small 
positive shift with the second protonation were also observed in the measurements of 10 and the protonated 
forms (Table 4-1).30d,31 In comparison of the redox potentials of the corresponding protonated species 
between 10 and 7, the redox potentials of 7 and the protonated forms are lower than those of 10 and the 
protonated forms, due to the ligand alteration of one π-accepting and neutral pyridine ligand of the TPA 
ligand in 10 with the π-donating and negatively-charged chloride ligand in 7, together with the charges of the 
complex cations. Combined with effects of the ligand alteration on the pKa values (14.3 for 10 and 16.4 for 
7) of the pterin ligand as mentioned above, the change of coordination environments and the charge of the 
complexes brought much impact on physical properties of the pterin complexes through change of the 
electron density of the RuII centers. 
The pKa values and the first oxidation potentials of 7 and those of the protonated forms obtained in this 
work allowed the author to draw “square schemes” of PCET reactions for 7 (Scheme 4-2) and also to 
calculate BDEs based on eq 1.16-19 In the case of MeCN as a solvent, the C value in eq 1 is estimated to be 
Scheme 4-1. Structures of complexes 7 and 10. 
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59.5 kcal mol–1 with use of redox potentials against the ferrocene/ferrocenium couple.15 Also in calculations, 
the potentials vs SCE are converted to the values against ferrocene/ferrocenium couple by subtraction of 0.40 
V.34 In this study, the author adopted BDE rather than bond dissociation free-energy (BDFE),35,36 because in 
this case a small contribution of the entropy term should be expected.36,37 The BDE values for the H-atom 
abstraction reaction from 7-H+ to give [RuIII(dmdmp)Cl(MeBPA)]+ (7OX) was calculated to be 78 kcal mol–1, 
and that for the reaction from 7-2H+ to give [RuIIICl(Hdmdmp)(MeBPA)]2+ (7OX-H+) was determined to be 
68 kcal mol–1. The BDE values for 7-H+ and 7-2H+ are slightly lower than those for the corresponding 10-H+ 
and 10-2H+ (85 and 75 kcal mol–1, respectively). Thus, complex 7OX is expected to show lower reactivity in 
PCET reactions than 10OX. 
 
4–3 1e– Oxidation of RuII-dmdmp Complexes 
Complexes 7 and 10 were oxidized with addition of 1 equiv of [FeIII(bpy)3]3+ (Ered = +1.10 V vs SCE)38 
Table 4-1. Oxidation Potentials (V vs SCE) of the Ru-pterin Complexes in MeCN 
Protonation status the pterin ligand 7 10a 
dmdmp– +0.24 +0.66 
Hdmdmp +0.54 +0.92 
H2dmdmp+ +0.62 +0.94 
a: these values are taken from ref. 32. 
Scheme 4-2. Thermochemical square schemes for multistep PCET of 7 (A) and 10 (B) in MeCN. 
 
E1/2 values are referenced to ferrocene/ferrocenium couple. *: calculated pKa values on the basis of eq 1. 
a Values taken from ref. 32. 
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as an oxidant in MeCN in accordance with the same procedure described in the previous report of our 
research group.32 The absorption spectrum of 7 in MeCN exhibited the absorption maxima at 392 and 493 
nm as shown as the red trace in Figure 4-1. Upon addition of the oxidant to the MeCN solution of 7, the 
spectrum of 7 changed with showing two isosbestic points at 372 and 510 nm as depicted in Figure 4-1A. In 
the course of the reaction, the increase of absorbance at 520 nm was observed due to the formation of 
[FeII(bpy)3]2+. The absorption spectrum of the 1e–-oxidized form of 7, 7OX, was obtained by subtraction of the 
spectrum of [FeII(bpy)3]2+ from the final spectrum (black line in Figure 4-1B) and the spectrum of 7OX 
exhibited the absorption maxima at 366 and 517 nm. 
 
4–4 Oxidation Reactivity of 7OX and 10OX toward C–H bonds of Hydrocarbons 
The 1e–-oxidized species of 7 and 10 (7OX and 10OX) reacted with substrates such as hydrocarbons. The 
oxidation reactions of organic substrates with 7OX and 10OX were monitored with a stopped-flow apparatus 
using a double-mixing mode. In the reaction of 7OX with 9,10-dihydroanthracene (DHA) as a substrate, the 
absorbance at 528 nm due to 7-H+ increased as shown in Figure 4-2A. In the reaction of 10OX with DHA, the 
absorbance at 497 nm, which was assigned to that of 10-H+,32 increased as can be seen in Figure 4-2B. The 
spectral changes indicate the formation of 7-H+ or 10-H+ in the course of the reaction of 7OX or 10OX with 
 
Figure 4-1. (A) UV-Vis spectral change in the course of the addition of [FeIII(bpy)3](PF6)3 as a 1e–-oxidant into the solution of 7 
(17.4 µM, red trace) up to 1 equiv in MeCN at room temperature. (B) UV-vis spectrum of the reaction mixture of 7 (17.4 µM) and 
[FeIII(bpy)3]2+ (blue trace), that of [FeII(bpy)3]2+ (17.4 µM, red trace) and (c) a differential spectrum of the former two traces (black 
trace) in MeCN at room temperature. 
 
Figure 4-2. Absorption spectral changes in the course of the reactions of DHA with 7OX (A) and 10OX (B) (0 – 10 s after addition 
of DHA), monitored by a stopped-flow spectrometer in MeCN at 296 K. [Ru] = 15 µM, [DHA] = 2.4 mM. 
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DHA. In both cases, characteristic absorption bands of anthracene as the product increased in the range of λ 
< 400 nm with a vibronic feature (Figure 4-2).39 In order to clarify the final products derived from 7OX and 
10OX in the DHA oxidation, the differential spectra were obtained by the subtraction of the spectrum of  
[Fe(bpy)3]2+ (15 µM in MeCN) from the final spectra of the reaction mixtures (Figure 4-3). The spectra of 
the products, shown as the black traces in Figure 4-3, are identical to the spectrum of 10-H+ as represented 
by the absorptions at 443 and 493 nm40 and that of 7-H+ as supported by the absorption at 549 nm, which is 
consistent with the green line in Figure 4-1B. Thus, it is concluded that a proton and an electron of a C-H 
bond of DHA are transferred to the N-1 position of the dmdmp– ligand and to the RuIII center, respectively, 
through a PCET mechanism as shown in Scheme 4-3. 
The absorbance changes of the solution containing 7OX at 530 nm obeyed pseudo first-order kinetics in 
the presence of an excess amount of DHA as shown in Figure 4-4A and curve-fitting of the time-course of 
 
Figure 4-3. Differential spectra obtained for the reactions of DHA with 7OX (A) and 10OX (B) in MeCN. The final spectra of the 
reactions: red, the spectrum of [FeII(bpy)3]2+ (15 µM): blue, the spectra obtained by (red) – (blue): black. 
Scheme 4-3. Reactions of 7OX with a substrate 
 
Ω
 
Figure 4-4. (A) The absorbance change at 530 nm (green dot) and the pesudo first-order fitting curve (orange line) in the course of 
the reaction of 7OX with DHA monitored by a stopped-flow spectrometer in MeCN at 296 K: [Ru] = 15 µM, [DHA] = 3.3 mM. 
Concentration dependence of kobs for the oxidation (green squares) of DHA (green squares, DHA-d0; blue squares, DHA-d4) and 
the fitting analysis (orange solid line) with 7OX (B) or 10OX (C) at 296 K in MeCN. [7OX]0 and [10OX]0 = 15 µM. 
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the absorbance at 530 nm allowed the author to determine a pseudo-first-order rate constant (kobs). On the 
basis of a plot of the kobs values versus the concentrations of the substrate (Figure 4-4B), the author 
determined the second-order rate constants (k) from the slope of the linear correlation as depicted in Figure 
4-4B. The k values of the DHA oxidation by 7OX and 10OX were determined to be 87 ± 2 M–1 s–1 and (2.5 ± 
0.1) × 102 M–1 s–1, respectively (Figure 4-4B and C). In accordance with this procedure, the k vales for C–H 
oxidation reactions of a series of substrates were determined in MeCN at 296 K (Figure 4-5 – 4-9). The 
second-order rate constants of oxidation reactions of other substrates by 7OX and 10OX are summarized in 
Table 4-2. 
Complexes 7OX and 10OX showed similar reactivity on the oxidation reaction of xanthene, with showing 
comparable rate constants: k = (8.7 ± 0.4) × 102 M–1 s–1 for 7OX and (1.32 ± 0.05) × 103 M–1 s–1 for 10OX. In 
contrast, for the C-H oxidation of other substrates, the reactivity of the two complexes were different; for 
example, the k value for the reaction of 1,2,3,4,5-pentamethyl-cyclopentadiene (HCp*) with 10OX was ca. 
100 times larger than that with 7OX: k = (5.7 ± 0.2) × 102 M–1 s–1 for 7OX and (6.0 ± 0.2) × 104 M–1 s–1 for 
Table 4-2. Oxidation Potentials, pKa and BDE Values of Hydrocarbons, and Second-Order Rate Constants of C-H Oxidation 
Reactions by 7OX or 10OX in MeCN at 296 K 
    k, M–1 s–1 
2s substrate Eox, V vs SCE pKa BDE, kcal mol–1 7OX 10OX 
xanthene +1.56a 41.0b 75.5c (8.7 ± 0.4) × 102 (1.32 ± 0.05) × 103 
DHA +2.13a 41.1b 76.3c 87 ± 2 (2.5 ± 0.1) × 102 
HCp* 
 
+0.95a 37.1b 77c (5.7 ± 0.2) × 102 (6.0 ± 0.2) × 104 
fluorene +1.58a 33.6b 82c 1.42 ± 0.02 35.5 ± 0.6 
indene +1.54a 31.1b 83c 0.24 ± 0.01 13 ± 1 
EtPh +2.41a — 85.4c too slow 0.50 ± 0.02 
a Determined by second-harmonic alternating current voltammetry (SHACV) in MeCN. b Values measured in DMSO (Ref. 41) 
and extrapolated to those in MeCN using the equation: pKa(C-H) (in MeCN) = 11 + pKa(C-H) (in DMSO) (Ref. 17). c Ref. 42.  
 
Figure 4-5. Concentration dependence of kobs for the oxidation (green squares) of HCp* (green squares for HCp*-d0, blue squares 
for HCp*-d1) and the fitting analysis (orange solid line) with 7OX (A) or 10OX (B) at 296 K in MeCN. [7OX]0 and [10OX]0 = 15 µM. 
 
Figure 4-6. Concentration dependence of kobs for the oxidation (green squares) of xanthene and the fitting analysis (orange solid 
line) with 7OX (A) or 10OX (B) at 296 K in MeCN. [7OX]0 and [10OX]0 = 15 µM. 
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10OX. In addition, the k values of the indene oxidation were 0.24 ± 0.01 M–1 s–1 for 7OX and 13 ± 1 M–1 s–1 for 
10OX, respectively. As for ethylbenzene (EtPh, BDEC-H = 85.4 kcal mol–1), complex 10OX showing the BDE 
value of 85 kcal mol–1 reacted slowly with the substrate at the rate constant of 0.50 ± 0.02 M–1 s–1; however, 
the reaction of 7OX showing the BDE value of 78 kcal mol–1 with ethylbenzene did not proceed, because of 
the energetically uphill situation in light of the BDE values of the oxidant and the substrate. This result is 
consistent with the relationship of the BDE values of both complexes and the substrates, indicating that the 
C-H oxidation by 7OX and 10OX proceed via CPET. 
Product analyses were conducted for the oxidation reactions of the respective substrates; the oxidation of 
DHA gave anthracene as mentioned above, and formation of xanthylium cation43 was suggested by 
absorption around ~370 nm in the oxidation of xanthene at high concentration (Figure 4-10). Attempts to 
detect the products of the oxidation reactions of other substrates were performed using GC-MS; however, no 
signals of organic products were detected.  
The indenyl radical, which is presumed to be formed from the oxidation of indene with 7OX and 10OX, has 
been known to polymerize rapidly;44 hence, the indenyl radical formed probably should further react rapidly 
to afford polymers, which are insensitive to the GC measurements. Supporting this, in SHACV 
 
Figure 4-9. Concentration dependence of kobs for the oxidation of EtPh (green squares for EtPh-d0, blue squares for EtPh-d10) and 
the fitting analysis (orange solid line) with 10OX at 296 K in MeCN. [10OX]0 = 15 µM. 
 
Figure 4-7. Concentration dependence of kobs for the oxidation (green squares) of fluorene and the fitting analysis (orange solid 
line) with 7OX (A) or 10OX (B) at 296 K in MeCN. [7OX]0 and [10OX]0 = 15 µM. 
 
Figure 4-8. Concentration dependence of kobs for the oxidation (green squares) of indene and the fitting analysis (orange solid 
line) with 7OX (A) or 10OX (B) at 296 K in MeCN. [7OX]0 and [10OX]0 = 15 µM. 
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measurements of an indene solution in MeCN, the working electrode (glassy carbon disk) was coated with 
brown materials, which were assumed to be indenyl polymers. In addition, the formation of the indenyl 
radical was confirmed by the detection of the ESR signal of a spin adduct using 2-Methyl-2-nitrosopropane 
(MNP) dimer as a spin trapping reagent; a triplet of doublets (g = 2.0064, AN = 14.7 G, AH = 2.4 G) was 
observed as shown in Figure 4-11A and assigned to a carbon radical with one hydrogen atom.45 The control 
experiments support that the short-lived indenyl radical should be formed in the reaction of indene with 10OX, 
not derived from self decomposition of MNP dimer (Figure 4-11F) and other possible oxidation reactions of 
indene by [FeIII(bpy)3]3+ (Figure 4-11C). 
Coating of the working electrode was also observed in the measurements of an HCp* solution in MeCN, 
and thus, oxidized HCp* is also assumed to form its polymers. C-H abstraction from fluorine at the 
9-position has been reported to afford 9H,9′H-[9,9′]bifluorenyl as a product;46 however, the author could not 
detect any dimeric products.  
To elucidate the C-H bond cleavage process, kinetic isotope effects (KIE) were investigated for the 
oxidation reactions of HCp* (HCp* and HCp*-d1) and DHA (DHA and DHA-d4) with 7OX or 10OX, and KIE 
for the oxidation reaction of ethylbenzene (EtPh and EtPh-d10) with 10OX was also determined. In the 
oxidation of DHA, both 7OX and 10OX showed relatively large KIE values: 4.5 ± 0.2 for 7OX and 4.2 ± 0.3 for 
10OX. For the oxidations of ethylbenzene with 10OX and HCp* by 7OX, KIE values were determined to be 
1.67 ± 0.08 and 8.1 ± 0.4, respectively. The four KIE values mentioned above indicated that the C-H 
oxidations proceed through a CPET mechanism rather than a stepwise PT/ET or ET/PT mechanism. In stark 
contrast, the oxidation reaction of HCp* with 10OX gave a small KIE value of 1.33 ± 0.06. Based on this 
small KIE value as well as the aforementioned much larger k value, the oxidation of HCp* with 10OX is 
proposed to proceed through an ET/PT mechanism, in which the PT step is the rate-determining step, rather 
than a CPET pathway. The lower Eox potential of HCp* (+0.95 V vs SCE) as compared to those of other 
substrates (+1.5 – 2.0 V vs SCE) probably provides the ET/PT mechanism with increasing the driving force 
of electron transfer from HCp* to the RuIII-pterin complex, 10OX. 
Plots of log k’ (k’ = k/n; n = number of equivalent hydrogen atoms to be abstracted) for C-H oxidations 
with 7OX and 10OX against BDE values of the C-H bonds to be cleaved were prepared to argue the difference 
of the mechanisms, depending on the substrates and the oxidants (Figure 4-12). In the case of 7OX, the log k’ 
values for the oxidation reactions of the five hydrocarbons showed a linear relationship with the BDE values 
as depicted in Figure 4-12A. In the case of 10OX, in contrast to the case of 7OX, a much higher k’ value was 
 
Figure 4-10. UV-Vis spectral change in the course of oxidation of xanthene with 10OX at 296 K in MeCN. [10OX] = 15 µM, [DHA] 
= 4.2 mM. 
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obtained for the aforementioned ET/PT oxidation of HCp* than those for other five substrates. Except HCp*, 
the log k’ values for the other five substrates showed a linear relationship relative to the BDE values of the 
C-H bonds, as depicted in Figure 4-12B. The linear correlations observed for the oxidation reactions by 7OX 
and 10OX indicate that the reactions proceed through a common mechanism. Thus, the oxidation of HCp* by 
10OX is concluded to proceed in a different mechanism, i.e., an ET/PT mechanism, as mentioned above. 
In general, the linear relationship between the second-order rate-constants and BDEs of the C-H bonds to 
be cleaved has been analyzed on the basis of the Bell-Evans-Polanyi (BEP) relation as expressed by the 
following equations 4 and 5:47,48 
 
Ea = a∆H° + C     (4) 
∆H° = BDEC–H to be cleaved + BDEfor oxidant   (5) 
 
Figure 4-11. ESR spectra of spin adducts formed in trapping reactions with MNP and those of control samples observed at room 
temperature under Ar atmosphere. (A) 10OX in MeCN/indene/MNP dimer in the dark; (B) 10OX in MeCN/indene in the dark; (C) 
[FeIII(bpy)3]3+ in MeCN/indene/MNP dimer in the dark; (D) 10OX in MeCN in the dark; (E) MNP dimer in MeCN in the dark; (F) 
MNP in MeCN under light irradiation (white light). ESR spectrometer conditions: micro wave power, 60 mW; modulation, 100.00 
kHz, 0.50 G; scan range, 3510 ± 25 G; gain, 1.00 × 104; scans, 7. Signals with an asterisk in (A) are those of MNP monomer 
depicted in (F) with AN = 15.6 G. 
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Logarithm of rate constants of C-H oxidation reactions by high-valent metal-oxo complexes, which are 
excellent oxidants to oxidize organic substrates, generally obey the BEP relation to give coefficients of α ~ –
0.5.49 In the case of a metal complex having a hydroxo ligand as a basic site as an oxidant in HAT, the α 
values have been reported by Stack and coworkers to be –0.1 (MnIII-OH)50 and –0.2 (FeIII-OH),51 which are 
smaller than those with metal-oxo complexes as oxidants. Except the oxidation of HCp* with 10OX, the log k’ 
values for oxidation reactions of hydrocarbons with 7OX and 10OX obeyed the BEP correlation and the 
coefficients α were determined to be –0.44 for 7OX and –0.27 for 10OX, respectively (Figure 4-12). Note that 
the α value for the C-H oxidation by 10OX is apparently negatively smaller than that obtained for the 
oxidation of phenol derivatives by 10OX (–0.44).32 The difference between the α values for 7OX and 10OX 
highlights distinguishable alteration of characteristics of PCET reactions by both oxidants. 
Leffler advocated that the coefficient α of the BEP correlations reflected the structure of the transition 
state;52 based on the Leffler’s discussion, a reaction passing through the transition state with the structure 
reminiscent of that of the product show a negatively larger α value, whereas that passing through the 
transition state with the structure reminiscent of that of the starting material affords a negatively smaller α 
value.50,51 From this viewpoint, the coefficient α of the oxidation reactions with 10OX suggest that the 
reaction proceeds via a transition state involving a structure close to the initial structure: The proton to be 
transferred should interact strongly with the attached carbon atom. On the contrary, the reactions by 7OX go 
through a transition state involving a structure close to the product compared to the case of 10OX and the 
proton should interact strongly with the N1 atom of the dmdmp– ligand than in the reaction with 10OX. 
The arguments can be supported by the difference of characteristics of the two complexes, in light of the 
redox potentials of the RuII/RuIII couples (+0.24 V for 7OX and +0.66 V for 10OX; see Table 4-1 and Scheme 
4-2), representing the electron-acceptability at the RuIII center, and the pKa values of the RuIII-bound dmdmp– 
ligand (11.3 for 7OX and 9.9 for 10OX see Scheme 4-2), standing for the proton-acceptability. Thus, complex 
7OX has lower electron-acceptability and higher proton-acceptability, whereas complex 10OX has higher 
electron-acceptability and lower proton-acceptability. Thus, the more basic complex 7OX pulls a proton from 
the substrate to be abstracted at the early stage of the oxidation reaction based on its high basicity to 
compensate its low electron acceptability (Scheme 4-4, left). The "proton-pulling" arrangement in the 
transition state induces the rise of electron acceptability of the RuIII center and lowering of the oxidation 
 
Figure 4-12. Plots of the log k’ values at 296 K for oxidation of five hydrocarbon substrates with 7OX (A) and with 10OX (B) 
against BDE values of C-H bonds to be cleaved in the substrates. In the linear fitting for (B), the k’ value for oxidation of HCp* is 
not included for the calculations. 
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potential of the substrate to be oxidized. On the other hand, since complex 10OX shows the higher 
electron-acceptability reflected on the higher redox potential, even though complex 10OX shows lower proton 
acceptability reflected on the lower pKa value, the complex requires not so much proton shift toward the 
dmdmp– ligand to gain large polarization of the C-H bond. Thus, it is concluded that the polarization of the 
C-H bond in the transition state can be controlled by the basicity of the proton acceptor site, even though the 
apparent BDE values are comparable, and this causes the difference of the reactivity of the oxidants in C-H 
oxidation. 
The activation parameters were determined from the kinetic measurements at several temperatures about 
oxidation of indene, DHA, xanthene, HCp*, and fluorene with 7OX and 10OX (Figure 4-13 and Table 4-3). 
Apart from oxidation of HCp*, complex 7OX shows negatively larger ∆S ‡ values and positively smaller ∆H‡ 
values than those of 10OX. The larger ∆S ‡ values of 7OX correspond to the aforementioned proposal about the 
transition states; i.e. complex 7OX preforms oxidation reactions via more strongly interacted transition states 
than that of 10OX. The smaller ∆H ‡ values of 7OX also correspond to difference between 10OX and 7OX; 
complex 7OX is expected to have higher basicity (calcd. pKa = 11.3) than that of 10OX (calcd. pKa = 9.9) and 
the higher basicity must provide stable formation of the complex between C-H bond to be cleaved and the 
dmdmp ligand of the oxidants in the transition state. 
In oxidation of HCp* with 7OX and 10OX, inverted tendency was observed in values of ∆S ‡ and ∆H ‡ ; 
complex 10OX shows negatively larger (or comparable) ∆S ‡ values and positively smaller ∆H ‡ values than 
these of 7OX. The deviation from the tendency can be explained by the aforementioned proposal that complex 
10OX oxidizes HCp* through a different process (ET/PT) from that by 7OX (CPET). This large ∆S ‡ value in 
the oxidation reaction of HCp* with 10OX can be attributed to the character of its transition state and the 
solvation. Among the oxidation reactions studied here, only that of HCp* with 10OX afforded radical cation 
species (HCp*•+) by ET instead of a neutral radical (Cp*•) by HAT. In outer-sphere electron transfer, 
reorganization of solvent molecules mainly controls the activation entropy of the reaction.53-55 MeCN 
employed in this study as the solvent is expected to firmly solvate the molecules in the transition state for the 
 
Figure 4-13. Eyring plots for the oxidation of DHA by 7OX (brown squares) and 10OX (blue triangles) in MeCN.  
Table 4-3. Activation Parameters for Oxidation of C-H Bonds with 7OX and 10OX. 
 7OX 10OX 
Substrates ∆S ‡ a ∆H ‡ b ∆S ‡ a ∆H ‡ b 
xanthene –32 ± 2 4.0 ± 0.6 –21 ± 2 6.9 ± 0.7 
DHA –33 ± 3 4.8 ± 0.8 –28 ± 1 5.6 ± 0.3 
HCp* –17 ± 5 9 ± 1 –21.5 ± 0.3 4.5 ± 0.7 
indene –49.1 ± 0.5 3.6 ± 0.1 –21 ± 5 9 ± 2 
fluorene –51.2 ± 0.4 2.0 ± 0.1 –44.9 ± 0.7 1.9 ± 0.2 
a cal K–1 mol–1 . b kcal mol–1 
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ET reaction from HCp* to 10OX, and the strong solvation probably provides the relatively large ∆S ‡. 
 
4–5 Summary 
The two RuII-pterin complexes employed in this work, 7 and 10, have similar structures to each other, 
and their corresponding 1e–-oxidized species (7OX and 10OX) show relatively comparable BDE values in the 
thermochemical square schemes of PCET. Complexes 7OX and 10OX, however, have difference in electron- 
and proton-acceptability; i.e. complex 10OX shows higher electron-acceptability than that of 7, whereas 
complex 7OX shows higher proton-acceptability than 10OX. To explore the impact of the electron- and 
proton-acceptability of the oxidant on the oxidation activity, the substrate oxidations with 7OX and 10OX were 
investigated on the basis of detailed kinetic analysis. Complexes 7OX and 10OX show the same reactivity in 
oxidation of substrates with relatively high pKa values such as xanthene, whereas in oxidation reactions of 
substrates with relatively small pKa values such as indene, complex 10OX showed a ca. 50 times larger rate 
constant than that with 7OX. BEP analysis for the oxidation reaction with 7OX and 10OX revealed that complex 
7OX attracts proton from the C-H bond of a substrate to make the bond more polarized for making electron 
transfer from the substrate more favorable. Therefore, pKa and Ered values of an oxidant are not only 
components of BDE, but also are significant factors to control the reactivity of the oxidant as a 
hydrogen-atom acceptor by affecting the transition-state structure in CPET oxidation reactions. 
  
Scheme 4-4. Proposed arrangements of the transition states in C-H oxidation by 7OX and 10OX. 
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Chapter 5 Concluding Remarks 
 
In this thesis, to shed lights on the characteristics of heteroaromatic coenzymes, a PQQ derivative and a 
pterin derivative, which are indispensable for biologically important oxidation reactions, transition-metal 
complexes having the heteroaromatic coenzymes as ligands have been synthesized and characterized in 
detail. The scope has been expanded to PCET oxidation reactions of C-H bonds of organic substrates, which 
have been argued on the basis of the detailed kinetic analysis to clarify the impact of the characteristic of 
oxidants on molecular arrangements in the transition states.  
In Chapter 2, two ruthenium(II)-silver(I)-PQQTME-terpy complexes (1 and 4) have been synthesized, 
and redox processes of their derivatives (2, and 5) have been investigated to reveal the influence of the metal 
coordination upon the electronic structures of their PQQTME ligands. The ruthenium(II) and silver(I) ions in 
1 are bound to the PQQTME ligand through the ONO and OO coordination sites, respectively, while the 
coordination sites of the ruthenium(II) and silver(I) ions in 4 are inverted from those in 1. Additionally, two 
RuII-AgI-PQQTME units in 4 are linked with a ring-structured AgI2(OTf)2 unit. By the difference in the 
coordination structures between 1 and 4, the stability gain in the complexation of the silver(I) ion with the 
PQQTME ligand in solution are controlled. When complex 1 was dissolved into a coordinating organic 
solvent, it lost the silver(I) ion to give a mononuclear ruthenium(II) complex, 2. On the other hand, when 
complex 4 was dissolved into a solvent such as aqueous MeCN or THF, 4 lost the AgI2(OTf)2 bridge and 
split into two parts, but the silver(I) ion bound at the ONO coordinating site did not dissociate to give two 
molecules of a RuII-AgI-heterodinuclear PQQTME complex 5, because of the higher stability in the 
coordination of the Ag(I) ion at the ONO tridentate site in 4 than that at the OO bidentate site in 1. The 
PQQTME ligands in 2 and 5 exhibited higher reduction potentials than those of PQQ in natural 
quinoproteins and free PQQTME, reflecting the high electron-acceptability of the bound ruthenium(II)-terpy 
unit. In addition, PQQTME in 5 showed a higher reduction potential than that in 2, and thus, the silver(I) ion 
in 5 played a role as a Lewis acid to raise the reduction potential of the PQQTME ligand. In consequence, 
the coordination of the silver(I) ion at the ONO-coordination site in 5 significantly strengthens the 
electron-acceptability of the PQQTME ligand. 
In Chapter 3, four pterin complexes (6-H+, 7-H+, 8, and 9) have been synthesized on the purpose to obtain 
pterin-OO-metal species, which is regarded as a plausible candidate of the active species in pterin-dependent 
hydroxylases. The pterin complexes and their protonated derivatives have been characterized especially with 
electrochemical measurements to obtain 1e–-reduced pterin species, because the target species can be formed 
by the reaction of the accessible 1e–-reduced pterin species with a O2•– ion. Among the pterin complexes 
studied here, only ruthenium(II)-(diprotonated pterin)-TPMOM complex, 6-2H+, gave a reversible reduction 
wave for the protonated pterin ligand in the CV measured in MeCN. Judging from the higher reduction 
potential and the reversibility of its 1e–-reduction behavior, complex 6-2H+ was regarded as the best 
candidate among the pterin complexes for the precursor to obtain the target pterin-OO-metal species. 
However, the target pterin-OO-metal species could not be obtained from 6-2H+, mainly due to the low 
protonation efficiency of 6 and decomposition of the chemical reductant in the presence of excessive amount 
of a strong acid added to the solution of 6. To solve these problems, introduction of alkyl groups to the N1 
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and N3 position of the pterin framework is one of the alternatives: The N-alkylated pterins are equivalent to 
the neutral or protonated pterin in terms of the electronic structures, and thus, a high reduction potential can 
be expected. On the other hand, the N-alkyl groups should be stable against the detachment in comparison 
with a proton, and thus, reversibility of the reduction processes is more prominent. 
As described in Chapter 4, 1e–-oxidized species of two pterin complexes, 7OX and 10OX, have been 
demonstrated to oxidize C-H bonds of hydrocarbons, which is rare for metal complexes having no oxo 
groups in the structure. In addition, Complex 7OX has higher proton-acceptability and lower 
electron-acceptability than 10OX, and thus, comparison of the reactivity between these oxidants can reveal the 
impacts of the proton- and electron-acceptability of oxidants on the mechanisms of PCET oxidation reactions 
at C-H bonds. In this study, it has been revealed that molecular arrangements of transition states in CPET 
reactions are affected by proton- and electron-acceptability of oxidants; i.e. an oxidant with high 
proton-acceptability and low electron acceptability involves a transition state having relatively more 
polarized C-H bond of a substrate to lower the oxidation potential of the substrate. 
Throughout this research, the author has revealed that ancillary ligands in transition-metal complexes of 
hereoaromatic coenzymes and protonation states of the coenzyme ligands severely affect reversibility of the 
reduction processes of the heteroaromatic coenzymes as ligands. Based on the results, the author has 
obtained important insights for molecular designs to form reduced coenzyme species in a metal coordination 
sphere. The strategy to improve the reversibility of the ligand reduction process and stabilize the 
ligand-reduced species by coordination to transition-metal complex moieties has been proved very effective 
also in this study. The studies on redox properties and reactivity of heteroaromatic enzymes will be more 
important to elucidate the biological functions and to gain mechanistic insights into biologically important 
reactions performed by enzymes using the heteroaromatic coenzymes as indispensable cofactors. Also, 
development of an oxidant in C-H oxidation without a metal-oxo group can provide a novel, clean, and 
sustainable strategy toward production of useful molecules and materials via energetically feasible PCET 
pathway. 
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Chapter 6 Experimental Section 
 
6–1 General 
Chemicals and solvents were used as received from Tokyo Chemical Industry (TCI) Co., Wako 
Chemicals, Nacalai Tesque or Sigma-Aldrich Corp. PQQTME,1-4 [RuCl3(terpy)],5 MeBPA,6,7 TPMOM,8 
[RuCl3(TPMOM)],9 Hdmdmp,10 [Ru(dmdmp)(TPA)]11 were prepared by the literature procedures. 
[RuIIICl3(MeBPA)] was prepared with a modified procedure reported by Shimizu et al..12 UV-vis spectra 
were collected on Shimadzu UV-3600 and Shimadzu UV-2450 spectrophotometers. 1H NMR measurements 
were made on JEOL EX-270 and JNM-ECS 400 spectrometers at room temperature. ESI-TOF- and 
GC-EI-MS spectra were measured on JEOL JMS-T100CS and SHIMADZU GC-2010 Plus spectrometers, 
respectively. Electrochemical measurements were performed on a BAS CV-1B voltammetric analyzer and 
an AUTOLAB PGSTAT12 potentiometer. ESR spectra were recorded on a Bruker EMXPlus 9.5/2.7 
spectrometer at 95 K, controlled by ER 4131VT and ER 4141VT temperature-control modules using liquid 
N2. 
 
6–2 Synthesis 
6–2–1 [(terpy)RuII(µ-PQQTME)AgI(OTf)2](OTf) (1·OTf) 
At first, the chloro ligands of [RuCl3(terpy)] were substituted with solvent molecules by a modified 
procedure of the Thibault’s method;13 to a dried Schlenk tube, [RuCl3(terpy)] (3.0 mg, 6.8 µmol) and AgOTf 
(11.4 mg, 44.6 µmol) were charged and then degassed H2O (5 mL) was added under argon atmosphere. The 
mixture was stirred at 55 °C for 60 min, cooled down to room temperature and then filtered through a 
membrane filter to remove AgCl formed. The brown filtrate was dried up for several hours in vacuo at < 
40 °C to give green solid of [Ru(terpy)(OH2)3](OTf)2. To the solid was added PQQTME (2.6 mg, 7.0 µmol) 
and dry 1,2-dichloroethane (2.5 mL), and then heated at reflux for 3 h under argon atmosphere. The reaction 
mixture was cooled down to room temperature and then filtered. Concentration of the filtrate under ambient 
pressure for 2 weeks gave green crystals and brown solution. Collection of the green crystals gave the title 
compound (5.0 mg, 4.0 µmol, 59%). Anal.: Calcd. for C35H23N5O17F9S3RuAg·2CH2Cl2·7H2O: C 28.53, H 
2.65, N 4.50. Found: C 28.50, H 2.41, N 4.76. ESI-TOF-MS (MeCN): m/z = 353.6 (calcd. for 
[RuII(PQQTME)(terpy)]2+: m/z = 353.5). 1H NMR (CD3CN): δ 3.91 (s, 3H, COOMe), 3.97 (s, 3H, COOMe), 
4.22 (s, 3H, 7-COOMe of PQQTME), 7.30 (d, J = 2.2 Hz, 1H, H3 of PQQTME), 7.48 (ddd, J = 7.7, 5.5, 1.1 
Hz, 2H, H5 of terpy), 7.81 (dd, J = 5.5, 1.1 Hz, 2H, H6 of terpy), 8.12 (td, J = 7.8, 1.1 Hz, 2H, H4 of terpy), 
8.39 (d, J = 7.9 Hz, 1H, H4' of terpy), 8.42 (dd, J = 7.9, 1.1 Hz, 2H, H4 of terpy), 8.54 (d, J = 7.9 Hz, 2H, 
H3' of terpy), 9.08 (s, 1H, H8 of PQQTME), 12.82 (br s, 1H, H1 of PQQTME). UV-Vis (DMF at –20 °C): 
λmax [nm] = 705, 476, 377, 338. 
6–2–2 [RuII(η3-PQQTME)(terpy)]2+ (2) 
Dissolving 1·OTf in MeCN gave a green solution of 2. ESI-TOF-MS (MeCN): m/z = 353.6 (calcd. for 
[Ru(PQQTME)-(terpy)]2+: m/z = 353.5). 1H NMR (CD3CN): δ 3.91 (s, 3H, COOMe), 3.97 (s, 3H, COOMe), 
4.22 (s, 3H, 7-COOMe of PQQTME), 7.30 (d, J = 2.2 Hz, 1H, H3 of PQQTME), 7.48 (ddd, J = 7.7, 5.5, 1.1 
Hz, 2H, H5 of terpy), 7.81 (dd, J = 5.5, 1.1 Hz, 2H, H6 of terpy), 8.12 (td, J = 7.8, 1.1 Hz, 2H, H4 of terpy), 
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8.39 (d, J = 7.9 Hz, 1H, H4' of terpy), 8.42 (dd, J = 7.9, 1.1 Hz, 2H, H4 of terpy), 8.54 (d, J = 7.9 Hz, 2H, 
H3' of terpy), 9.08 (s, 1H, H8 of PQQTME), 12.82 (br s, 1H, H1 of PQQTME). UV-Vis (DMF at –20 °C): 
λmax [nm] = 705, 476, 377, 338. 
6–2–3 [RuII(terpy)(η2-PQQTME)(MeCN)] (PF6)2 (3) 
Dissolving 1·OTf into an MeCN solution of TBAPF6 gave a green solution of 2 as mentioned above. A 
single crystal of 3 was obtained by slow concentration of the solution for several days in the presence of 
CHCl3 vapor as a poor solubility solvent. This incorporation of the poor solubility solvent into the solution 
could cause a reduction in the solubility of the complex and the appearance of crystals. HR-MS (MeCN): m/z 
= 374.0444 (calcd for [RuII(PQQTME)(terpy)(MeCN)]2+ : m/z = 374.0428). 1H NMR (CD3CN): δ 3.91 (s, 
3H, COOMe), 3.99 (s, 3H, COOMe), 4.10 (s, 3H, 7-COOMe of PQQTME), 7.35 (d, J = 2.2 Hz, 1H, H3 of 
PQQTME), 7.48 (ddd, J = 6.6, 5.5, 2.2 Hz, 2H, H5 of terpy), 8.17 (ddd, J = 8.6, 6.6, 1.6 Hz, 2H, H4 of 
terpy), 8.37 (t, J = 8.2 Hz, 1H, H4′ of terpy), 8.39 (d, J = 8.6 Hz, 2H, H3 of terpy), 8.62 (d, J = 8.2 Hz, 2H, 
H3′ of terpy), 8.73 (s, 1H, H8 of PQQTME), 8.89 (dd, J = 5.5, 1.6 Hz, 2H, H6 of terpy). 
6–2–4 [{(terpy)(OH2)RuII(µ-PQQTME)AgI(OTf)(µ-OTf)}2{(OTf)AgI(µ-OTf)2AgI(OTf)}] (4) 
Complex 4 was synthesized by a similar procedure of complex 1. To a dried Schlenk tube, [RuCl3(terpy)] 
(5.9 mg, 13 µmol) and AgOTf (27.5 mg, 100 µmol) were charged and then degassed H2O (5 mL) was added 
under argon atmosphere. The mixture was stirred at 50 °C for 50 min. The mixture was cooled down to room 
temperature and then filtered through a membrane to remove precipitated AgCl.13 The brown filtrate was 
dried up for several hours in vacuo at < 40 °C to give green solid of [Ru(terpy)(OH2)3](OTf)2. To the solid 
was added PQQTME (5.0 mg, 13 µmol) and dry 1,2-dichloroethane (10 mL), and then heated at reflux for 11 
h under argon atmosphere. The reaction mixture was cooled down to room temperature and then filtered. 
Concentration of the filtrate under ambient pressure for 2 weeks gave dark-green crystals and brown solution. 
Collection of the dark-green crystals gave the title compound (15.2 mg, 4.9 µmol, 75%). Anal.: Calcd. for 
C72H46N10O40F24S8Ru2Ag4·2ClCH2CH2Cl·3H2O: C 27.75, H 1.84, N 4.25. Found: C 28.01, H 2.11, N 4.48. 
ESI-TOF-MS (MeCN/H2O): m/z = 964.9 (calcd. for [(terpy)RuII(PQQTME•–)AgI(TfO–)]+: m/z = 964.9). 
UV-Vis (DMF at – 50 °C): λmax [nm] = 723, 484, 376, 318. 
6–2–5 [RuIICl(TPMOM)(Hdmdmp)](PF6) (6-H+•PF6) 
To a mixture of [RuIIICl3(TPMOM)] (56 mg, 0.12 mmol) and Hdmdmp (24.8 mg, 113 µmol) was added a 
mixture of ethanol (48 mL) and water (12 mL), and the mixture was heated at reflux. Color change of the 
mixture from brown to dark red was observed immediately after heating, and further reflux for 8.5 h gave 
dark purple solution. This obtained solution was dried up and the residual solid was dissolved into MeOH. 
Addition of NH4PF6 and ether caused precipitation of title compound as dark purple powder, and that was 
collected by filtration. ESI-TOF-MS (acetone): m/z = 633.1 (calcd. for {[RuIICl(Hdmdmp)(MeBPA)]}+: m/z 
= 633.1). 1H NMR (CD3CN): δ 1.83 (s, 3H, 7-Me), 2.57 (s, 3H, 6-Me), 3.28 (s, 6H, NMe2), 4.08 (s, 3H, 
OMe), 6.98 (dd, J = 7.5, 5.5 Hz, 1H, H5 of pyridine-A), 7.20 (dd, J = 8.0, 5.7 Hz, 1H, H5 of pyridine-B), 
7.42 (dd, J = 8.0, 6.1 Hz, 1H, H5 of pyridine-C), 7.74 (d, J = 5.5 Hz, 1H, H6 of pyridine-A), 7.81 (td, J = 7.5, 
1.4 Hz, 1H, H4 of pyridine-A), 7.84 (ddd, J = 8.0, 7.7, 1.4 Hz, 1H, H4 of pyridine-B), 7.94 (ddd, J = 8.0, 7.8, 
1.3 Hz, 1H, H4 of pyridine-C), 7.97 (d, J = 7.7 Hz, 1H, H3 of pyridine-A), 8.02 (d, J = 7.7 Hz, 1H, H3 of 
pyridine-B), 8.03 (d, J = 7.8 Hz, 1H, H3 of pyridine-C), 9.26 (dd, J = 5.7, 1.4 Hz, 1H, H6 of pyridine-B), 
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9.29 (dd, J = 6.1, 1.3 Hz, 1H, H6 of pyridine-C) 9.85 (br s, 1H, NH). 
6–2–6 [RuIICl(dmdmp)(MeBPA)] (7) 
To a mixture of [RuIIICl3(MeBPA)] (56.6 mg, 135 µmol) and Hdmdmp (32.5 mg, 148 µmol) was added 
ethanol (48 mL), and then water (12 mL) was poured into the suspension. The mixture obtained was 
degassed and heated at reflux under argon. Color change of the mixture from brown to dark red was 
observed immediately after heating, and further reflux for 12 h gave dark purple solution. This solution was 
filtered and Et3N (10 mL, 72 mmol) was added to the filtrate. EtOAc (150 mL) was added to the red solution 
obtained and the mixture was concentrated to half a volume to give brown suspension. Filtration of the 
suspension gave brown powder and colorless needles, the latter of which were assumed to be (Et3NH)Cl. 
The solid mixture was dissolved into methanol, and the target compound was separated with column 
chromatography on Sephadex LH20 eluted with MeOH. The first dark-red fraction was collected, and further 
purification was performed with column chromatography on Sephadex LH20 eluted with MeOH. After 
adding EtOAc into the red fraction eluted, the solution was concentrated to give dark purple solution with 
brown powder. The suspension was filtered, and the obtained solid was washed with EtOAc and diethyl 
ether gave the target compound as brown powder (30.6 mg, 53.8 µmol, 40%). Anal.: Calcd. for 
C23H27N8OClRu·0.5H2O·0.5MeOH: C 47.59, H 5.10, N 18.89. Found: C 47.87, H 4.84, N 18.91. 
ESI-TOF-MS (MeOH): m/z = 591.1 (calcd. for {Na+ + [RuII(dmdmp)(Cl)(MeBPA)]}+: m/z = 591.2). 1H 
NMR (CD3CN): δ 2.12 (s, 3H, 7-Me), 2.18 (s, 3H, CH3 of MeBPA), 2.23 (s, 3H, 6-Me), 2.52 (s, 6H, NMe2), 
3.89 – 4.12 (m, 4H, CH2), 7.03 (ddd, J = 7.7, 5.8, 1.2 Hz, 1H, H5 of pyridine-A), 7.06 (dd, J = 7.7, 1.2 Hz, 
1H, H3 of pyridine-A), 7.15 (ddd, J = 7.7, 6.3, 1.1 Hz, 1H, 5H of pyridine-B), 7.23 (dd, J = 7.2, 1.1 Hz, 1H, 
H3 of pyridine-B), 7.39 (td, J = 7.7, 1.2 Hz, 1H, H4 of pyridine-A), 7.57 (ddd, J = 7.7, 7.2, 1.1 Hz, 1H, H4 
of pyridine-B), 9.46 (dd, J = 5.8, 1.2 Hz, 1H, H4 of pyridine-A), 9.56 (dd, J = 6.3, 1.1 Hz, 1H, H6 of 
pyridine-B). UV-Vis (MeCN): λmax [nm] = 392, 495. 
6–2–7 [RuIICl(Hdmdmp)(MeBPA)](PF6) (7-H+·PF6) 
Recrystallization of crude 7-H+, which was prepared by the method mentioned above, from 
acetone/octane in the presence of NH4PF6 gave dark purple crystals. Anal.: Calcd. for C23H28N8OF6PClRu: C 
38.69, H 3.95, N 15.69. Found: C 38.97, H 3.94, N 15.38. ESI-TOF-MS (MeOH): m/z = 569.1 (calcd. for 
{[RuIICl(Hdmdmp)(MeBPA)]}+: m/z = 569.1). UV-Vis (MeCN): λmax [nm] = 326, 363, 549. 
6–2–8 [RhIIICl3(TPMOM)] 
RhIIICl3·nH2O (Rh content: 40 w/w%, 49.68 mg, 193 µmol) and TPMOM (54.9 mg, 197 µmol) were 
heated in EtOH (5 mL) for 10 h to give pale yellow suspension. Filtration of the suspension gave the title 
compound as pale yellow powder (79.8 mg, 164 µmol, 85%). Anal.: Calcd. for C17H15N3ORhCl3: C 41.96, H 
3.11, N 8.64. Found: C 41.85, H 3.11, N 8.40. 1H NMR ((CD3)2SO): δ 4.18 (s, 3H, -OMe), 7.69 (ddd, J = 8.2, 
6.9, 1.6 Hz, 3H, H4 of pyridine), 8.13 (dd, J = 8.2, 1.1 Hz, 3H, H3 of pyridine), 8.20 (ddd, J = 6.9, 6.1, 1.1 
Hz, 3H, H5 of pyridine), 9.23 (d, J = 6.1 Hz, 3H, H6 of pyridine).  
6–2–9 [RhIII(dmdmp)Cl(TPMOM)]Cl (8·Cl) 
To a mixture of Hdmdmp (25.10 mg, 114 µmol) and [RhIIICl3(TPMOM)] (54.30 mg, 112 µmol), were 
added EtOH (8 mL) and H2O (2 mL). Obtained yellow suspension was heated at reflux for 13.5 h to obtain 
yellow solution, and then this solution was filtered. Concentration of the filtrate and addition of ether into the 
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filtrate caused precipitation of yellow solid of a crude mixture including the target compound, and the solid 
was collected by filtration. Purification with column chromatography on Sephadex LH 20 eluted with MeOH 
and recrystallization from MeOH gave the title compound as pale yellow crystal (3.32 mg, 5.0 µmol, 4%). 
ESI-TOF-MS (MeOH): m/z = 633.2 (calcd. for {[RhIII(dmdmp)(Cl)(TPMOM)]}+: m/z = 633.1). 1H NMR 
((CD3)2OD): δ 1.84 (s, 3H, 7-Me), 2.65 (s, 3H, 6-Me), 4.31 (s, 3H, -OMe), 7.51 (ddd, J = 6.1, 6.8, 1.7 Hz, 
1H, H5 of pyridine-A), 7.69 (ddd, J = 8.0, 5.4, 1.6 Hz, 1H, H5 of pyridine-C), 7.75 (td, J = 6.0, 4.4, 1.6 Hz, 
1H, H5 of pyridine-B), 8.11 (d, J = 6.1 Hz, 1H, H6 of pyridine A), 8.28 – 8.37 (m, 3H, H4 of pyridine-B, H3 
of pyridine-A, H3 of pyridine-C), 8.38 (td, J = 8.0, 1.8 Hz, 1H, H4 of pyridine-C), 8.44 (d, J = 8.0 Hz, 1H, 
H3 of pyridine-B), 9.34 (dd, J = 6.0, 1.1 Hz, 1H, H6 of pyridine-B), 9.37 (dd, J = 5.4, 1.8 Hz, 1H, H6 of 
pyridine-C). 
6–2–10 [RhIIICl3(MeBPA)] 
To red solution of RhIIICl3·nH2O (Rh content: 40 w/w%, 121 mg, 470 µmol) in EtOH (10 mL) was added 
MeBPA (51 mg, 239 µmol), and precipitate immediately appeared in the mixture. The mixture was heated at 
reflux for 0.5 h and yellow suspension was obtained. The suspension was filtered, and the obtained solid was 
washed with H2O, MeCN, and ether to give yellow powder (115.84 mg) as a crude product including the 
target compound. Recrystallization from DMSO gave yellow powder (49.40 mg, 117 µmol, 49%) of pure 
[RhIIICl3(MeBPA)]. Anal.: Calcd. for C13H15N3RhCl3: C 36.95, H 3.58, N 9.94. Found: C 36.98, H 3.53, N 
9.66. 1H NMR ((CD3)2SO): δ 3.19 (s, 3H, -NMe), 4.58 and 4.91 (ABq, JAB = 16.9 Hz, 4H, -CH2-) 7.49 (d, J 
= 7.1 Hz, 2H, H3 of pyridine), 7.50 (t, J = 7.7 Hz, 2H, H5 of pyridine), 7.91 (dd, J = 7.7, 7.1 Hz, 2H, H4 of 
pyridine), 9.19 (d, J = 7.1 Hz, 2H, H6 of pyridine). 
6–2–11 [RhIII(dmdmp)Cl(MeBPA)]Cl (9·Cl) 
EtOH (4 mL) and H2O (2 mL) were added to a mixture of Hdmdmp (11.80 mg, 53.9 µmol) and 
[RhIIICl3(MeBPA)] (12.01 mg, 28.4 µmol), and then, Et3N (16 µL, ~110 µmol) was added. A yellow 
suspension obtained was heated at reflux for 18.5 h under Ar to give a yellow solution(?), and this solution 
was concentrated to half the volume. Addition of 1,2-dichloroethane into the solution caused separation 
between aqueous and organic layers, and addition of ether to the collected organic layer brought precipitation. 
Filtration of the suspension gave the title compound as yellowish brown powder (9.79 mg, 16.2 µmol, 57%). 
Anal.: Calcd. for C24H34N8O3.5RhCl2: C 43.39, H 5.16, N 16.90. Found: C 43.26, H 5.04, N 16.61. 
ESI-TOF-MS (MeOH): m/z = 569.1 (calcd. for {[RhIII(dmdmp–)Cl–(MeBPA)]}+: m/z = 569.1). 1H NMR 
((CD3)2OD): δ 2.03 (s, 3H, 7-Me), 2.15 (s, 3H, -NMe), 2.68 (s, 6-Me), 4.86 and 4.93 (ABq, JAB = 14.4 Hz, 
4H, -CH2-), 7.56 – 7.62 (m, 2H, H5 of pyridines), 7.62 – 7.69 (m, 2H, H3 of pyridines), 8.05 – 8.11 (m, 2H, 
H4 of pyridines), 9.37 (d, J = 5.3 Hz, 1H, H6 of pyridine), 9.46 (d, J = 5.7 Hz, 1H, H6 of pyridine). 
 
6–3 X-ray Diffraction Analyses 
All crystallographic measurements were performed at 120 K on a Bruker APEXII diffractometer with 
graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The structures were solved by a direct method 
(SIR–97) and expanded with differential Fourier technique. All non–hydrogen atoms were refined 
anisotropically and the structure refinements were carried out with full matrix least squares on F. All 
calculations were performed by using the Yadokari–XG program package.14 
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6–3–1 [{(terpy)(OH2)RuII(µ-PQQTME)AgI(OTf)(µ-OTf)}2{(OTf)AgI(µ-OTf)2AgI(OTf)}] (4) 
A single crystal of 4 was obtained by slow concentration of the filtrate of the reaction mixture with crude 
[RuII(OH2)3(terpy)]2+ (containing silver salt) and PQQTME in 1,2-dichloroethane (see 6-2-4). 
Crystallographic data: C36H25Ag2F12N5O21RuS4, FW = 1536.66, green-brown, triclinic, P 1, a = 13.628(2) Å, 
b = 13.863(2) Å, c = 15.446(2) Å, α = 102.265(2)°, β = 100.557(2)°, γ = 96.661(2)°, V = 2766.5(7) Å3, Z = 2, 
Dcalc = 1.845 g/cm3, F000 = 1508, R1 = 0.0541 (I > 2.00σ(I)), wR = 0.1043 (all data), GOF = 0.905. 
6–3–2 [RuII(terpy)(η2-PQQTME)(MeCN)](PF6)2 (3·(PF6)2) 
A single crystal of 3·(PF6)2 was obtained by slow concentration of an MeCN solution of 1 in the presence 
of CHCl3 as a poor solvent. Crystallographic data: C34H26F12N6O8P2Ru, FW = 1037.61, green, monoclinic, 
P21/n, a = 27.114(3) Å, b = 12.8194(16) Å, c = 33.802(4) Å, β = 98.429(2)°, V = 11622.2(3) Å3, Z = 8, Dcalc 
= 1.186 g/cm3, F000 = 4144, R1 = 0.0686 (I > 2.00σ(I)), wR = 0.0888 (all data), GOF = 1.065. 
6–3–3 [RuII(dmdmp)Cl(MeBPA)] (7) 
A single crystal of 7 was obtained by slow concentration of an CD3CN solution of 7. Crystallographic 
data: C23H27ClN8ORu, FW = 568.04, brown, monoclinic, P21, a = 8.702(3) Å, b = 12.587(4) Å, c = 
11.310(4) Å, β = 106.492(4)°, V = 1187.9(7) Å3, Z = 2, Dcalc = 1.588 g/cm3, F000 = 580, R1 = 0.0398 (I > 
2.00σ(I)), wR = 0.1124 (all data), GOF = 0.850. 
6–3–4 [RuIICl(MeBPA)(Hdmdmp)] (7-H+·(PF6)) 
A single crystal of (7-H+)·(PF6) was obtained by slow concentration of an (CD3)2CO solution of 
(7-H+)·(PF6). Crystallographic data: C23H28ClF6N8OPRu, FW = 714.02, purple, monoclinic, P21/c, a = 
9.1261(12) Å, b = 17.015(2) Å, c = 18.767(2) Å, β = 96.562(2)°, V = 2894.9(6) Å3, Z = 4, Dcalc = 1.638 
g/cm3, F000 = 1440, R1 = 0.0376 (I > 2.00σ(I)), wR = 0.1456 (all data), GOF = 1.201. 
6–3–5 [RhIII(dmdmp)Cl(TPMOM)]Cl (8·Cl) 
A single crystal of 8·Cl was obtained by slow concentration of a CH2Cl2 solution of 8·Cl. 
Crystallographic data: C27H27Cl2N8O3Ru, FW = 685.37, yellow, monoclinic, C2/c, a = 20.3867(18) Å, b = 
13.1090(11) Å, c = 21.5581(19) Å, β = 100.0270(10)°, V = 5673.4(9) Å3, Z = 8, Dcalc = 1.605 g/cm3, F000 = 
2784, R1 = 0.0458 (I > 2.00σ(I)), wR = 0.1315 (all data), GOF = 1.060. 
 
6–4 DFT Calculations 
The structures of free PQQTME, 1, 2, 1e–-reduced species of 2 ([RuII(PQQTME•–)(terpy)]+), 5, and 1e–
-reduced species of 5 ([{RuII(terpy)(OH2)}(PQQTME•–){AgI(OTf)2}]) were optimized by using the B3LYP 
functional.15 The SDD basis set16 was used for Ru and Ag atoms and the D95** basis set17 for H, C, N, F, 
and S atoms. The Gaussian 09 program package18 was used for all DFT calculations. 
 
6–5 Kinetic Measurements 
Kinetic measurements described in Chapter 4 were performed on a UNISOKU RSP-2000 stopped-flow 
spectrometer equipped with a multi-channel photodiode array using a double-mixing mode at 296 K in 
superdehydrated grade MeCN (Wako Pure Chemical Industries) as a solvent. RuII-dmdmp complexes (7 or 
10: 15 µM) were treated with [FeIII(bpy)3](PF6)3 (15 µM) to generate the corresponding RuIII-dmdmp 
complexes (7OX and 10OX). After an incubation time of 1.0 s, substrates were added to the solution. The 
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spectral changes were monitored by the rise of the absorption band centered at 530 nm due to the formation 
of RuII-Hdmdmp complexes (7-H+ and 10-H+). The kinetic measurements were carried out at 296 K under 
pseudo first-order conditions, where the concentrations of the substrate were set at more than 100-fold excess 
to the RuIII-dmdmp complexes. Pseudo first-order rate constants (kobs) were determined by least-square curve 
fittings for the absorbance changes at 530 nm on the basis of eq 2: 
A = A∞ exp(1 – kobst)     (2) 
where A and A∞ refer to the absorbance at 530 nm at the moment of t and at the infinite time after the 
initiation of the reaction. A linear fit to the plot of the kobs values obtained against the concentration of the 
substrate gave the second-order rate constant, k, as the slope (eq 3). 
kobs = k [substrate]0      (3) 
 
6–6 Determination of the pKa values in MeCN 
UV-vis titrations of 6-H+ were performed with use of 2,4,6-trimethylpyridine (Me3Py) as a base for the 
determination of pKa values of 6-H+. A solution of Me3Py (37.9 mM) in MeCN was added dropwise to a 
MeCN solution (3.0 mL) of 6-H+ (18.9 µM) in a quartz cell and UV-vis spectrum was measured after each 
addition. The absorbance change at 560 nm was analyzed using eq 4: 
A – A0 = (ε6-H+ – ε6)[K1([Me3Py]0 + [6-H+]0) – {K12([Me3Py]0 + [6-H+]0)2 –4K1(K1 – 1) × 
[Me3Py]0[6-H+]0}1/2]/2(K1 – 1)   (4) 
where A0 refers to the absorbance of 6-H+ at the wavelength and K1 represents the equilibrium constant of the 
reaction between 6-H+ and Me3Py; ε6-H+ = 4060, ε6 = 1660 at 560 nm. Based on eq 4, K1 was determined to 
be 0.37 ± 0.02. Thus, the pKa value of 6-H+ was calculated using the K1 value obtained and the pKa value of 
Me3Py (14.98)19 based on eq 5. 
pKa = –log K1 + pKa(HMe3Py+)   (5) 
The pKa of 6-2H+ was determined through a similar procedure using trifluoromethane-sulfonic acid 
(TfOH) as an acid. A solution of TfOH (56.5 mM) in MeCN was added dropwise to a MeCN solution (3.0 
mL) of 6-H+ (18.9 µM) in a quartz cell, and UV-vis spectra were measured after each addition. The 
absorbance change at 660 nm was analyzed using eq 6: 
A’ – A0’ = (ε6-H+ – ε6-2H+)[K2([TfOH]0 + [6-H+]0) – {K22([TfOH]0 + [6-H+]0)2 –4K2(K2 – 1) × 
[TfOH]0[6-H+]0}1/2]/2(K2 – 1)   (6) 
where A0’ refers to the absorbance of 6-H+ at the wavelength and K2 is the equilibrium constant of the 
reaction between 6-H+ and TfOH; ε6-H+ = 1580, ε6-2H+ = 1200 at 549 nm. Based on eq 6, K2 was determined to 
be 0.15 ± 0.01. Thus, the pKa value of 6-2H+ was calculated on the basis of the K2 value obtained and the pKa 
value of TfOH (2.6)20 based on eq 7. 
pKa = log K2 + pKa(TfOH)   (7) 
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UV-vis titrations of 7-H+, which was formed by addition of 1 equiv of TfOH, were performed with use of 
Me3Py as a base for the determination of pKa values of 7-H+. A solution of Me3Py (37.9 mM) in MeCN was 
added dropwise to a MeCN solution (3.0 mL) of 7-H+ (20.1 µM) in a quartz cell and UV-vis spectrum was 
measured after each addition. The absorbance change at 430 nm was analyzed using eq 8: 
A – A0 = (ε7-H+ – ε7)[K3([Me3Py]0 + [7-H+]0) – {K32([Me3Py]0 + [7-H+]0)2 –4K3(K3 – 1) × 
[Me3Py]0[7-H+]0}1/2]/2(K3 – 1)   (8) 
where A0 refers to the absorbance of 7-H+ at the wavelength and K3 represents the equilibrium constant of the 
reaction between 7-H+ and Me3Py; ε7-H+ = 2340, ε7 = 7960 at 430 nm. Based on eq 8, K3 was determined to 
be (4.08 ± 0.02) × 10–2. Thus, the pKa value of 7-H+ was calculated using the K3 value obtained and the pKa 
value of Me3Py (14.98)19 based on eq 9. 
pKa = –log K3 + pKa(HMe3Py+)   (9) 
The pKa of 7-2H+ was determined through a similar procedure using TfOH as an acid. A solution of 
TfOH (56.5 mM) in MeCN was added dropwise to a MeCN solution (3.0 mL) of 7-H+ (17.4 µM) in a quartz 
cell, and UV-vis spectra were measured after each addition. The absorbance change at 549 nm was analyzed 
using eq 10: 
A’ – A0’ = (ε7-H+ – ε7-2H+)[K4([TfOH]0 + [7-H+]0) – {K42([TfOH]0 + [7-H+]0)2 –4K4(K4 – 1) × 
[TfOH]0[7-H+]0}1/2]/2(K2 – 1)   (10) 
where A0’ refers to the absorbance of 7-H+ at the wavelength and K4 is the equilibrium constant of the 
reaction between 7-H+ and TfOH; ε7-H+ = 9390, ε7-2H+ = 2400 at 549 nm. Based on eq 10, K4 was determined 
to be 19 ± 2. Thus, the pKa value of 7-2H+ was calculated on the basis of the K4 value obtained and the pKa 
value of TfOH (2.6)20 based on eq 11. 
pKa = log K4 + pKa(TfOH)   (11) 
UV-vis titrations of 10-H+, which was formed by addition of 1 equiv of TfOH, were performed with use 
of Me3Py as a base for the determination of pKa values of 10-H+ via a similar procedure to that of 6-H+. A 
solution of Me3Py (37.9 mM) in MeCN was added dropwise to a MeCN solution (3.0 mL) of 10-H+ (19.6 
µM) in a quartz cell and UV-vis spectrum was measured after each addition. The absorbance change at 430 
nm was analyzed using eq 12: 
A’’ – A0’’ = (ε10-H+ – ε10)[K5([Me3Py]0 + [10-H+]0) – {K52([Me3Py]0 + [10-H+]0)2 –4K5(K5 – 1) 
× [Me3Py]0[10-H+]0}1/2]/2(K5 – 1)  (12) 
where A0’’ refers to the absorbance of 10-H+ at the wavelength and K5 represents the equilibrium constant of 
the reaction between 10-H+ and Me3Py; ε10-H+ = 9970, ε10 = 14870 at 430 nm. Based on eq 12, K5 was 
determined to be 5.4 ± 0.3. Thus, the pKa value of 10-H+ was calculated using the K5 value obtained and the 
pKa value of Me3Py (14.98)19 based on eq 13. 
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pKa = –log K5 + pKa(HMe3Py+)   (13) 
 
The pKa values of protonated rhodium-pterin complexes, 8-H+ and 9-H+ were also determined via a 
similar procedure to those of ruthenium-pterin complexes. A solution of TfOH (56.5 mM) in MeCN was 
added dropwise to a MeCN solution (3.0 mL) of 8 (20.0 µM) in a quartz cell, and UV-vis spectra were 
measured after each addition. The absorbance change at 420 nm was analyzed using eq 14: 
A’ – A0’ = (ε8 – ε8-H+)[K6([TfOH]0 + [8]0) – {K62([TfOH]0 + [8]0)2 –4K6(K6 – 1) × 
[TfOH]0[8]0}1/2]/2(K6 – 1)   (14) 
where A0’ refers to the absorbance of 8 at the wavelength and K6 is the equilibrium constant of the reaction 
between 8 and TfOH; ε8 = 5030, ε8-H+ = 200 at 420 nm. Based on eq 15, K6 was determined to be 5.1 ± 0.6. 
Thus, the pKa value of 8-H+ was calculated on the basis of the K6 value obtained and the pKa value of TfOH 
(2.6)20 based on eq 15. 
pKa = log K6 + pKa(TfOH)   (15)  
A solution of TfOH (56.5 mM) in MeCN was added dropwise to a MeCN solution (3.0 mL) of 9 (22.0 
µM) in a quartz cell, and UV-vis spectra were measured after each addition. The absorbance change at 411 
nm was analyzed using eq 16: 
A’ – A0’ = (ε9 – ε9-H+)[K7([TfOH]0 + [9]0) – {K72([TfOH]0 + [9]0)2 –4K7(K7 – 1) × 
[TfOH]0[9]0}1/2]/2(K7 – 1)   (16) 
where A0’ refers to the absorbance of 9 at the wavelength and K7 is the equilibrium constant of the reaction 
between 9 and TfOH; ε9 = 5250, ε9-H+ = 220 at 420 nm. Based on eq 16, K7 was determined to be 6.0 ± 0.6. 
Thus, the pKa value of 9-H+ was calculated on the basis of the K7 value obtained and the pKa value of TfOH 
(2.6)20 based on eq 17. 
pKa = log K7 + pKa(TfOH)   (17)  
 
6–7 Attempt to Formation of pterin-OO-metal Species with 6-2H+ in Propionitrile 
To 3.0 mL of a propionitrile solution of 6-H+ (49.9 µM, 150 nmol) in a quartz cell was added 10.0 µL 
(113 µmol) of TfOH under Ar at RT. Color of the solution was changed into green, indicating that 6-2H+ 
was formed. The green solution was cooled to –85 °C, and cobaltocene (~ 4 mM) in propionitrile was added 
dropwise to the 6-2H+ solution, and UV-vis spectra were measured after each addition. After addition of 
~1800 nmol of cabaltocene, the MLCT band of the 6-2H+ around 660 nm was completely disappeared. To 
the solution a mixture of KO2 (63 mg, 0.89 mmol) and 18-crown-6 (118 mg, 0.451 mmol) in 2 mL of 
benzene was added dropwise by 10 µL. In the course of the addition of KO2 into the reduced 6-2H+, no 
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absorption bands were observed over 400 nm. 
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